BindingDB Reactant_set_id	Ligand SMILES	Ligand InChI	Ligand InChI Key	BindingDB MonomerID	BindingDB Ligand Name	Target Name	Target Source Organism According to Curator or DataSource	Ki (nM)	IC50 (nM)	Kd (nM)	EC50 (nM)	kon (M-1-s-1)	koff (s-1)	pH	Temp (C)	Curation/DataSource	Article DOI	BindingDB Entry DOI	PMID	PubChem AID	Patent Number	Authors	Date of publication	Date in BindingDB	Institution	Link to Ligand in BindingDB	Link to Target in BindingDB	Link to Ligand-Target Pair in BindingDB	Ligand HET ID in PDB	PDB ID(s) for Ligand-Target Complex	PubChem CID	PubChem SID	ChEBI ID of Ligand	ChEMBL ID of Ligand	DrugBank ID of Ligand	IUPHAR_GRAC ID of Ligand	KEGG ID of Ligand	ZINC ID of Ligand	Number of Protein Chains in Target (>1 implies a multichain complex)	BindingDB Target Chain Sequence 1	PDB ID(s) of Target Chain 1	UniProt (SwissProt) Recommended Name of Target Chain 1	UniProt (SwissProt) Entry Name of Target Chain 1	UniProt (SwissProt) Primary ID of Target Chain 1	UniProt (SwissProt) Secondary ID(s) of Target Chain 1	UniProt (SwissProt) Alternative ID(s) of Target Chain 1	UniProt (TrEMBL) Submitted Name of Target Chain 1	UniProt (TrEMBL) Entry Name of Target Chain 1	UniProt (TrEMBL) Primary ID of Target Chain 1	UniProt (TrEMBL) Secondary ID(s) of Target Chain 1	UniProt (TrEMBL) Alternative ID(s) of Target Chain 1	BindingDB Target Chain Sequence 2	PDB ID(s) of Target Chain 2	UniProt (SwissProt) Recommended Name of Target Chain 2	UniProt (SwissProt) Entry Name of Target Chain 2	UniProt (SwissProt) Primary ID of Target Chain 2	UniProt (SwissProt) Secondary ID(s) of Target Chain 2	UniProt (SwissProt) Alternative ID(s) of Target Chain 2	UniProt (TrEMBL) Submitted Name of Target Chain 2	UniProt (TrEMBL) Entry Name of Target Chain 2	UniProt (TrEMBL) Primary ID of Target Chain 2	UniProt (TrEMBL) Secondary ID(s) of Target Chain 2	UniProt (TrEMBL) Alternative ID(s) of Target Chain 2	BindingDB Target Chain Sequence 3	PDB ID(s) of Target Chain 3	UniProt (SwissProt) Recommended Name of Target Chain 3	UniProt (SwissProt) Entry Name of Target Chain 3	UniProt (SwissProt) Primary ID of Target Chain 3	UniProt (SwissProt) Secondary ID(s) of Target Chain 3	UniProt (SwissProt) Alternative ID(s) of Target Chain 3	UniProt (TrEMBL) Submitted Name of Target Chain 3	UniProt (TrEMBL) Entry Name of Target Chain 3	UniProt (TrEMBL) Primary ID of Target Chain 3	UniProt (TrEMBL) Secondary ID(s) of Target Chain 3	UniProt (TrEMBL) Alternative ID(s) of Target Chain 3	BindingDB Target Chain Sequence 4	PDB ID(s) of Target Chain 4	UniProt (SwissProt) Recommended Name of Target Chain 4	UniProt (SwissProt) Entry Name of Target Chain 4	UniProt (SwissProt) Primary ID of Target Chain 4	UniProt (SwissProt) Secondary ID(s) of Target Chain 4	UniProt (SwissProt) Alternative ID(s) of Target Chain 4	UniProt (TrEMBL) Submitted Name of Target Chain 4	UniProt (TrEMBL) Entry Name of Target Chain 4	UniProt (TrEMBL) Primary ID of Target Chain 4	UniProt (TrEMBL) Secondary ID(s) of Target Chain 4	UniProt (TrEMBL) Alternative ID(s) of Target Chain 4	BindingDB Target Chain Sequence 5	PDB ID(s) of Target Chain 5	UniProt (SwissProt) Recommended Name of Target Chain 5	UniProt (SwissProt) Entry Name of Target Chain 5	UniProt (SwissProt) Primary ID of Target Chain 5	UniProt (SwissProt) Secondary ID(s) of Target Chain 5	UniProt (SwissProt) Alternative ID(s) of Target Chain 5	UniProt (TrEMBL) Submitted Name of Target Chain 5	UniProt (TrEMBL) Entry Name of Target Chain 5	UniProt (TrEMBL) Primary ID of Target Chain 5	UniProt (TrEMBL) Secondary ID(s) of Target Chain 5	UniProt (TrEMBL) Alternative ID(s) of Target Chain 5	BindingDB Target Chain Sequence 6	PDB ID(s) of Target Chain 6	UniProt (SwissProt) Recommended Name of Target Chain 6	UniProt (SwissProt) Entry Name of Target Chain 6	UniProt (SwissProt) Primary ID of Target Chain 6	UniProt (SwissProt) Secondary ID(s) of Target Chain 6	UniProt (SwissProt) Alternative ID(s) of Target Chain 6	UniProt (TrEMBL) Submitted Name of Target Chain 6	UniProt (TrEMBL) Entry Name of Target Chain 6	UniProt (TrEMBL) Primary ID of Target Chain 6	UniProt (TrEMBL) Secondary ID(s) of Target Chain 6	UniProt (TrEMBL) Alternative ID(s) of Target Chain 6	BindingDB Target Chain Sequence 7	PDB ID(s) of Target Chain 7	UniProt (SwissProt) Recommended Name of Target Chain 7	UniProt (SwissProt) Entry Name of Target Chain 7	UniProt (SwissProt) Primary ID of Target Chain 7	UniProt (SwissProt) Secondary ID(s) of Target Chain 7	UniProt (SwissProt) Alternative ID(s) of Target Chain 7	UniProt (TrEMBL) Submitted Name of Target Chain 7	UniProt (TrEMBL) Entry Name of Target Chain 7	UniProt (TrEMBL) Primary ID of Target Chain 7	UniProt (TrEMBL) Secondary ID(s) of Target Chain 7	UniProt (TrEMBL) Alternative ID(s) of Target Chain 7	BindingDB Target Chain Sequence 8	PDB ID(s) of Target Chain 8	UniProt (SwissProt) Recommended Name of Target Chain 8	UniProt (SwissProt) Entry Name of Target Chain 8	UniProt (SwissProt) Primary ID of Target Chain 8	UniProt (SwissProt) Secondary ID(s) of Target Chain 8	UniProt (SwissProt) Alternative ID(s) of Target Chain 8	UniProt (TrEMBL) Submitted Name of Target Chain 8	UniProt (TrEMBL) Entry Name of Target Chain 8	UniProt (TrEMBL) Primary ID of Target Chain 8	UniProt (TrEMBL) Secondary ID(s) of Target Chain 8	UniProt (TrEMBL) Alternative ID(s) of Target Chain 8	BindingDB Target Chain Sequence 9	PDB ID(s) of Target Chain 9	UniProt (SwissProt) Recommended Name of Target Chain 9	UniProt (SwissProt) Entry Name of Target Chain 9	UniProt (SwissProt) Primary ID of Target Chain 9	UniProt (SwissProt) Secondary ID(s) of Target Chain 9	UniProt (SwissProt) Alternative ID(s) of Target Chain 9	UniProt (TrEMBL) Submitted Name of Target Chain 9	UniProt (TrEMBL) Entry Name of Target Chain 9	UniProt (TrEMBL) Primary ID of Target Chain 9	UniProt (TrEMBL) Secondary ID(s) of Target Chain 9	UniProt (TrEMBL) Alternative ID(s) of Target Chain 9	BindingDB Target Chain Sequence 10	PDB ID(s) of Target Chain 10	UniProt (SwissProt) Recommended Name of Target Chain 10	UniProt (SwissProt) Entry Name of Target Chain 10	UniProt (SwissProt) Primary ID of Target Chain 10	UniProt (SwissProt) Secondary ID(s) of Target Chain 10	UniProt (SwissProt) Alternative ID(s) of Target Chain 10	UniProt (TrEMBL) Submitted Name of Target Chain 10	UniProt (TrEMBL) Entry Name of Target Chain 10	UniProt (TrEMBL) Primary ID of Target Chain 10	UniProt (TrEMBL) Secondary ID(s) of Target Chain 10	UniProt (TrEMBL) Alternative ID(s) of Target Chain 10	BindingDB Target Chain Sequence 11	PDB ID(s) of Target Chain 11	UniProt (SwissProt) Recommended Name of Target Chain 11	UniProt (SwissProt) Entry Name of Target Chain 11	UniProt (SwissProt) Primary ID of Target Chain 11	UniProt (SwissProt) Secondary ID(s) of Target Chain 11	UniProt (SwissProt) Alternative ID(s) of Target Chain 11	UniProt (TrEMBL) Submitted Name of Target Chain 11	UniProt (TrEMBL) Entry Name of Target Chain 11	UniProt (TrEMBL) Primary ID of Target Chain 11	UniProt (TrEMBL) Secondary ID(s) of Target Chain 11	UniProt (TrEMBL) Alternative ID(s) of Target Chain 11	BindingDB Target Chain Sequence 12	PDB ID(s) of Target Chain 12	UniProt (SwissProt) Recommended Name of Target Chain 12	UniProt (SwissProt) Entry Name of Target Chain 12	UniProt (SwissProt) Primary ID of Target Chain 12	UniProt (SwissProt) Secondary ID(s) of Target Chain 12	UniProt (SwissProt) Alternative ID(s) of Target Chain 12	UniProt (TrEMBL) Submitted Name of Target Chain 12	UniProt (TrEMBL) Entry Name of Target Chain 12	UniProt (TrEMBL) Primary ID of Target Chain 12	UniProt (TrEMBL) Secondary ID(s) of Target Chain 12	UniProt (TrEMBL) Alternative ID(s) of Target Chain 12	BindingDB Target Chain Sequence 13	PDB ID(s) of Target Chain 13	UniProt (SwissProt) Recommended Name of Target Chain 13	UniProt (SwissProt) Entry Name of Target Chain 13	UniProt (SwissProt) Primary ID of Target Chain 13	UniProt (SwissProt) Secondary ID(s) of Target Chain 13	UniProt (SwissProt) Alternative ID(s) of Target Chain 13	UniProt (TrEMBL) Submitted Name of Target Chain 13	UniProt (TrEMBL) Entry Name of Target Chain 13	UniProt (TrEMBL) Primary ID of Target Chain 13	UniProt (TrEMBL) Secondary ID(s) of Target Chain 13	UniProt (TrEMBL) Alternative ID(s) of Target Chain 13	BindingDB Target Chain Sequence 14	PDB ID(s) of Target Chain 14	UniProt (SwissProt) Recommended Name of Target Chain 14	UniProt (SwissProt) Entry Name of Target Chain 14	UniProt (SwissProt) Primary ID of Target Chain 14	UniProt (SwissProt) Secondary ID(s) of Target Chain 14	UniProt (SwissProt) Alternative ID(s) of Target Chain 14	UniProt (TrEMBL) Submitted Name of Target Chain 14	UniProt (TrEMBL) Entry Name of Target Chain 14	UniProt (TrEMBL) Primary ID of Target Chain 14	UniProt (TrEMBL) Secondary ID(s) of Target Chain 14	UniProt (TrEMBL) Alternative ID(s) of Target Chain 14	BindingDB Target Chain Sequence 15	PDB ID(s) of Target Chain 15	UniProt (SwissProt) Recommended Name of Target Chain 15	UniProt (SwissProt) Entry Name of Target Chain 15	UniProt (SwissProt) Primary ID of Target Chain 15	UniProt (SwissProt) Secondary ID(s) of Target Chain 15	UniProt (SwissProt) Alternative ID(s) of Target Chain 15	UniProt (TrEMBL) Submitted Name of Target Chain 15	UniProt (TrEMBL) Entry Name of Target Chain 15	UniProt (TrEMBL) Primary ID of Target Chain 15	UniProt (TrEMBL) Secondary ID(s) of Target Chain 15	UniProt (TrEMBL) Alternative ID(s) of Target Chain 15	BindingDB Target Chain Sequence 16	PDB ID(s) of Target Chain 16	UniProt (SwissProt) Recommended Name of Target Chain 16	UniProt (SwissProt) Entry Name of Target Chain 16	UniProt (SwissProt) Primary ID of Target Chain 16	UniProt (SwissProt) Secondary ID(s) of Target Chain 16	UniProt (SwissProt) Alternative ID(s) of Target Chain 16	UniProt (TrEMBL) Submitted Name of Target Chain 16	UniProt (TrEMBL) Entry Name of Target Chain 16	UniProt (TrEMBL) Primary ID of Target Chain 16	UniProt (TrEMBL) Secondary ID(s) of Target Chain 16	UniProt (TrEMBL) Alternative ID(s) of Target Chain 16	BindingDB Target Chain Sequence 17	PDB ID(s) of Target Chain 17	UniProt (SwissProt) Recommended Name of Target Chain 17	UniProt (SwissProt) Entry Name of Target Chain 17	UniProt (SwissProt) Primary ID of Target Chain 17	UniProt (SwissProt) Secondary ID(s) of Target Chain 17	UniProt (SwissProt) Alternative ID(s) of Target Chain 17	UniProt (TrEMBL) Submitted Name of Target Chain 17	UniProt (TrEMBL) Entry Name of Target Chain 17	UniProt (TrEMBL) Primary ID of Target Chain 17	UniProt (TrEMBL) Secondary ID(s) of Target Chain 17	UniProt (TrEMBL) Alternative ID(s) of Target Chain 17	BindingDB Target Chain Sequence 18	PDB ID(s) of Target Chain 18	UniProt (SwissProt) Recommended Name of Target Chain 18	UniProt (SwissProt) Entry Name of Target Chain 18	UniProt (SwissProt) Primary ID of Target Chain 18	UniProt (SwissProt) Secondary ID(s) of Target Chain 18	UniProt (SwissProt) Alternative ID(s) of Target Chain 18	UniProt (TrEMBL) Submitted Name of Target Chain 18	UniProt (TrEMBL) Entry Name of Target Chain 18	UniProt (TrEMBL) Primary ID of Target Chain 18	UniProt (TrEMBL) Secondary ID(s) of Target Chain 18	UniProt (TrEMBL) Alternative ID(s) of Target Chain 18	BindingDB Target Chain Sequence 19	PDB ID(s) of Target Chain 19	UniProt (SwissProt) Recommended Name of Target Chain 19	UniProt (SwissProt) Entry Name of Target Chain 19	UniProt (SwissProt) Primary ID of Target Chain 19	UniProt (SwissProt) Secondary ID(s) of Target Chain 19	UniProt (SwissProt) Alternative ID(s) of Target Chain 19	UniProt (TrEMBL) Submitted Name of Target Chain 19	UniProt (TrEMBL) Entry Name of Target Chain 19	UniProt (TrEMBL) Primary ID of Target Chain 19	UniProt (TrEMBL) Secondary ID(s) of Target Chain 19	UniProt (TrEMBL) Alternative ID(s) of Target Chain 19	BindingDB Target Chain Sequence 20	PDB ID(s) of Target Chain 20	UniProt (SwissProt) Recommended Name of Target Chain 20	UniProt (SwissProt) Entry Name of Target Chain 20	UniProt (SwissProt) Primary ID of Target Chain 20	UniProt (SwissProt) Secondary ID(s) of Target Chain 20	UniProt (SwissProt) Alternative ID(s) of Target Chain 20	UniProt (TrEMBL) Submitted Name of Target Chain 20	UniProt (TrEMBL) Entry Name of Target Chain 20	UniProt (TrEMBL) Primary ID of Target Chain 20	UniProt (TrEMBL) Secondary ID(s) of Target Chain 20	UniProt (TrEMBL) Alternative ID(s) of Target Chain 20	BindingDB Target Chain Sequence 21	PDB ID(s) of Target Chain 21	UniProt (SwissProt) Recommended Name of Target Chain 21	UniProt (SwissProt) Entry Name of Target Chain 21	UniProt (SwissProt) Primary ID of Target Chain 21	UniProt (SwissProt) Secondary ID(s) of Target Chain 21	UniProt (SwissProt) Alternative ID(s) of Target Chain 21	UniProt (TrEMBL) Submitted Name of Target Chain 21	UniProt (TrEMBL) Entry Name of Target Chain 21	UniProt (TrEMBL) Primary ID of Target Chain 21	UniProt (TrEMBL) Secondary ID(s) of Target Chain 21	UniProt (TrEMBL) Alternative ID(s) of Target Chain 21	BindingDB Target Chain Sequence 22	PDB ID(s) of Target Chain 22	UniProt (SwissProt) Recommended Name of Target Chain 22	UniProt (SwissProt) Entry Name of Target Chain 22	UniProt (SwissProt) Primary ID of Target Chain 22	UniProt (SwissProt) Secondary ID(s) of Target Chain 22	UniProt (SwissProt) Alternative ID(s) of Target Chain 22	UniProt (TrEMBL) Submitted Name of Target Chain 22	UniProt (TrEMBL) Entry Name of Target Chain 22	UniProt (TrEMBL) Primary ID of Target Chain 22	UniProt (TrEMBL) Secondary ID(s) of Target Chain 22	UniProt (TrEMBL) Alternative ID(s) of Target Chain 22	BindingDB Target Chain Sequence 23	PDB ID(s) of Target Chain 23	UniProt (SwissProt) Recommended Name of Target Chain 23	UniProt (SwissProt) Entry Name of Target Chain 23	UniProt (SwissProt) Primary ID of Target Chain 23	UniProt (SwissProt) Secondary ID(s) of Target Chain 23	UniProt (SwissProt) Alternative ID(s) of Target Chain 23	UniProt (TrEMBL) Submitted Name of Target Chain 23	UniProt (TrEMBL) Entry Name of Target Chain 23	UniProt (TrEMBL) Primary ID of Target Chain 23	UniProt (TrEMBL) Secondary ID(s) of Target Chain 23	UniProt (TrEMBL) Alternative ID(s) of Target Chain 23	BindingDB Target Chain Sequence 24	PDB ID(s) of Target Chain 24	UniProt (SwissProt) Recommended Name of Target Chain 24	UniProt (SwissProt) Entry Name of Target Chain 24	UniProt (SwissProt) Primary ID of Target Chain 24	UniProt (SwissProt) Secondary ID(s) of Target Chain 24	UniProt (SwissProt) Alternative ID(s) of Target Chain 24	UniProt (TrEMBL) Submitted Name of Target Chain 24	UniProt (TrEMBL) Entry Name of Target Chain 24	UniProt (TrEMBL) Primary ID of Target Chain 24	UniProt (TrEMBL) Secondary ID(s) of Target Chain 24	UniProt (TrEMBL) Alternative ID(s) of Target Chain 24	BindingDB Target Chain Sequence 25	PDB ID(s) of Target Chain 25	UniProt (SwissProt) Recommended Name of Target Chain 25	UniProt (SwissProt) Entry Name of Target Chain 25	UniProt (SwissProt) Primary ID of Target Chain 25	UniProt (SwissProt) Secondary ID(s) of Target Chain 25	UniProt (SwissProt) Alternative ID(s) of Target Chain 25	UniProt (TrEMBL) Submitted Name of Target Chain 25	UniProt (TrEMBL) Entry Name of Target Chain 25	UniProt (TrEMBL) Primary ID of Target Chain 25	UniProt (TrEMBL) Secondary ID(s) of Target Chain 25	UniProt (TrEMBL) Alternative ID(s) of Target Chain 25	BindingDB Target Chain Sequence 26	PDB ID(s) of Target Chain 26	UniProt (SwissProt) Recommended Name of Target Chain 26	UniProt (SwissProt) Entry Name of Target Chain 26	UniProt (SwissProt) Primary ID of Target Chain 26	UniProt (SwissProt) Secondary ID(s) of Target Chain 26	UniProt (SwissProt) Alternative ID(s) of Target Chain 26	UniProt (TrEMBL) Submitted Name of Target Chain 26	UniProt (TrEMBL) Entry Name of Target Chain 26	UniProt (TrEMBL) Primary ID of Target Chain 26	UniProt (TrEMBL) Secondary ID(s) of Target Chain 26	UniProt (TrEMBL) Alternative ID(s) of Target Chain 26	BindingDB Target Chain Sequence 27	PDB ID(s) of Target Chain 27	UniProt (SwissProt) Recommended Name of Target Chain 27	UniProt (SwissProt) Entry Name of Target Chain 27	UniProt (SwissProt) Primary ID of Target Chain 27	UniProt (SwissProt) Secondary ID(s) of Target Chain 27	UniProt (SwissProt) Alternative ID(s) of Target Chain 27	UniProt (TrEMBL) Submitted Name of Target Chain 27	UniProt (TrEMBL) Entry Name of Target Chain 27	UniProt (TrEMBL) Primary ID of Target Chain 27	UniProt (TrEMBL) Secondary ID(s) of Target Chain 27	UniProt (TrEMBL) Alternative ID(s) of Target Chain 27	BindingDB Target Chain Sequence 28	PDB ID(s) of Target Chain 28	UniProt (SwissProt) Recommended Name of Target Chain 28	UniProt (SwissProt) Entry Name of Target Chain 28	UniProt (SwissProt) Primary ID of Target Chain 28	UniProt (SwissProt) Secondary ID(s) of Target Chain 28	UniProt (SwissProt) Alternative ID(s) of Target Chain 28	UniProt (TrEMBL) Submitted Name of Target Chain 28	UniProt (TrEMBL) Entry Name of Target Chain 28	UniProt (TrEMBL) Primary ID of Target Chain 28	UniProt (TrEMBL) Secondary ID(s) of Target Chain 28	UniProt (TrEMBL) Alternative ID(s) of Target Chain 28	BindingDB Target Chain Sequence 29	PDB ID(s) of Target Chain 29	UniProt (SwissProt) Recommended Name of Target Chain 29	UniProt (SwissProt) Entry Name of Target Chain 29	UniProt (SwissProt) Primary ID of Target Chain 29	UniProt (SwissProt) Secondary ID(s) of Target Chain 29	UniProt (SwissProt) Alternative ID(s) of Target Chain 29	UniProt (TrEMBL) Submitted Name of Target Chain 29	UniProt (TrEMBL) Entry Name of Target Chain 29	UniProt (TrEMBL) Primary ID of Target Chain 29	UniProt (TrEMBL) Secondary ID(s) of Target Chain 29	UniProt (TrEMBL) Alternative ID(s) of Target Chain 29	BindingDB Target Chain Sequence 30	PDB ID(s) of Target Chain 30	UniProt (SwissProt) Recommended Name of Target Chain 30	UniProt (SwissProt) Entry Name of Target Chain 30	UniProt (SwissProt) Primary ID of Target Chain 30	UniProt (SwissProt) Secondary ID(s) of Target Chain 30	UniProt (SwissProt) Alternative ID(s) of Target Chain 30	UniProt (TrEMBL) Submitted Name of Target Chain 30	UniProt (TrEMBL) Entry Name of Target Chain 30	UniProt (TrEMBL) Primary ID of Target Chain 30	UniProt (TrEMBL) Secondary ID(s) of Target Chain 30	UniProt (TrEMBL) Alternative ID(s) of Target Chain 30	BindingDB Target Chain Sequence 31	PDB ID(s) of Target Chain 31	UniProt (SwissProt) Recommended Name of Target Chain 31	UniProt (SwissProt) Entry Name of Target Chain 31	UniProt (SwissProt) Primary ID of Target Chain 31	UniProt (SwissProt) Secondary ID(s) of Target Chain 31	UniProt (SwissProt) Alternative ID(s) of Target Chain 31	UniProt (TrEMBL) Submitted Name of Target Chain 31	UniProt (TrEMBL) Entry Name of Target Chain 31	UniProt (TrEMBL) Primary ID of Target Chain 31	UniProt (TrEMBL) Secondary ID(s) of Target Chain 31	UniProt (TrEMBL) Alternative ID(s) of Target Chain 31	BindingDB Target Chain Sequence 32	PDB ID(s) of Target Chain 32	UniProt (SwissProt) Recommended Name of Target Chain 32	UniProt (SwissProt) Entry Name of Target Chain 32	UniProt (SwissProt) Primary ID of Target Chain 32	UniProt (SwissProt) Secondary ID(s) of Target Chain 32	UniProt (SwissProt) Alternative ID(s) of Target Chain 32	UniProt (TrEMBL) Submitted Name of Target Chain 32	UniProt (TrEMBL) Entry Name of Target Chain 32	UniProt (TrEMBL) Primary ID of Target Chain 32	UniProt (TrEMBL) Secondary ID(s) of Target Chain 32	UniProt (TrEMBL) Alternative ID(s) of Target Chain 32	BindingDB Target Chain Sequence 33	PDB ID(s) of Target Chain 33	UniProt (SwissProt) Recommended Name of Target Chain 33	UniProt (SwissProt) Entry Name of Target Chain 33	UniProt (SwissProt) Primary ID of Target Chain 33	UniProt (SwissProt) Secondary ID(s) of Target Chain 33	UniProt (SwissProt) Alternative ID(s) of Target Chain 33	UniProt (TrEMBL) Submitted Name of Target Chain 33	UniProt (TrEMBL) Entry Name of Target Chain 33	UniProt (TrEMBL) Primary ID of Target Chain 33	UniProt (TrEMBL) Secondary ID(s) of Target Chain 33	UniProt (TrEMBL) Alternative ID(s) of Target Chain 33	BindingDB Target Chain Sequence 34	PDB ID(s) of Target Chain 34	UniProt (SwissProt) Recommended Name of Target Chain 34	UniProt (SwissProt) Entry Name of Target Chain 34	UniProt (SwissProt) Primary ID of Target Chain 34	UniProt (SwissProt) Secondary ID(s) of Target Chain 34	UniProt (SwissProt) Alternative ID(s) of Target Chain 34	UniProt (TrEMBL) Submitted Name of Target Chain 34	UniProt (TrEMBL) Entry Name of Target Chain 34	UniProt (TrEMBL) Primary ID of Target Chain 34	UniProt (TrEMBL) Secondary ID(s) of Target Chain 34	UniProt (TrEMBL) Alternative ID(s) of Target Chain 34	BindingDB Target Chain Sequence 35	PDB ID(s) of Target Chain 35	UniProt (SwissProt) Recommended Name of Target Chain 35	UniProt (SwissProt) Entry Name of Target Chain 35	UniProt (SwissProt) Primary ID of Target Chain 35	UniProt (SwissProt) Secondary ID(s) of Target Chain 35	UniProt (SwissProt) Alternative ID(s) of Target Chain 35	UniProt (TrEMBL) Submitted Name of Target Chain 35	UniProt (TrEMBL) Entry Name of Target Chain 35	UniProt (TrEMBL) Primary ID of Target Chain 35	UniProt (TrEMBL) Secondary ID(s) of Target Chain 35	UniProt (TrEMBL) Alternative ID(s) of Target Chain 35	BindingDB Target Chain Sequence 36	PDB ID(s) of Target Chain 36	UniProt (SwissProt) Recommended Name of Target Chain 36	UniProt (SwissProt) Entry Name of Target Chain 36	UniProt (SwissProt) Primary ID of Target Chain 36	UniProt (SwissProt) Secondary ID(s) of Target Chain 36	UniProt (SwissProt) Alternative ID(s) of Target Chain 36	UniProt (TrEMBL) Submitted Name of Target Chain 36	UniProt (TrEMBL) Entry Name of Target Chain 36	UniProt (TrEMBL) Primary ID of Target Chain 36	UniProt (TrEMBL) Secondary ID(s) of Target Chain 36	UniProt (TrEMBL) Alternative ID(s) of Target Chain 36	BindingDB Target Chain Sequence 37	PDB ID(s) of Target Chain 37	UniProt (SwissProt) Recommended Name of Target Chain 37	UniProt (SwissProt) Entry Name of Target Chain 37	UniProt (SwissProt) Primary ID of Target Chain 37	UniProt (SwissProt) Secondary ID(s) of Target Chain 37	UniProt (SwissProt) Alternative ID(s) of Target Chain 37	UniProt (TrEMBL) Submitted Name of Target Chain 37	UniProt (TrEMBL) Entry Name of Target Chain 37	UniProt (TrEMBL) Primary ID of Target Chain 37	UniProt (TrEMBL) Secondary ID(s) of Target Chain 37	UniProt (TrEMBL) Alternative ID(s) of Target Chain 37	BindingDB Target Chain Sequence 38	PDB ID(s) of Target Chain 38	UniProt (SwissProt) Recommended Name of Target Chain 38	UniProt (SwissProt) Entry Name of Target Chain 38	UniProt (SwissProt) Primary ID of Target Chain 38	UniProt (SwissProt) Secondary ID(s) of Target Chain 38	UniProt (SwissProt) Alternative ID(s) of Target Chain 38	UniProt (TrEMBL) Submitted Name of Target Chain 38	UniProt (TrEMBL) Entry Name of Target Chain 38	UniProt (TrEMBL) Primary ID of Target Chain 38	UniProt (TrEMBL) Secondary ID(s) of Target Chain 38	UniProt (TrEMBL) Alternative ID(s) of Target Chain 38	BindingDB Target Chain Sequence 39	PDB ID(s) of Target Chain 39	UniProt (SwissProt) Recommended Name of Target Chain 39	UniProt (SwissProt) Entry Name of Target Chain 39	UniProt (SwissProt) Primary ID of Target Chain 39	UniProt (SwissProt) Secondary ID(s) of Target Chain 39	UniProt (SwissProt) Alternative ID(s) of Target Chain 39	UniProt (TrEMBL) Submitted Name of Target Chain 39	UniProt (TrEMBL) Entry Name of Target Chain 39	UniProt (TrEMBL) Primary ID of Target Chain 39	UniProt (TrEMBL) Secondary ID(s) of Target Chain 39	UniProt (TrEMBL) Alternative ID(s) of Target Chain 39	BindingDB Target Chain Sequence 40	PDB ID(s) of Target Chain 40	UniProt (SwissProt) Recommended Name of Target Chain 40	UniProt (SwissProt) Entry Name of Target Chain 40	UniProt (SwissProt) Primary ID of Target Chain 40	UniProt (SwissProt) Secondary ID(s) of Target Chain 40	UniProt (SwissProt) Alternative ID(s) of Target Chain 40	UniProt (TrEMBL) Submitted Name of Target Chain 40	UniProt (TrEMBL) Entry Name of Target Chain 40	UniProt (TrEMBL) Primary ID of Target Chain 40	UniProt (TrEMBL) Secondary ID(s) of Target Chain 40	UniProt (TrEMBL) Alternative ID(s) of Target Chain 40	BindingDB Target Chain Sequence 41	PDB ID(s) of Target Chain 41	UniProt (SwissProt) Recommended Name of Target Chain 41	UniProt (SwissProt) Entry Name of Target Chain 41	UniProt (SwissProt) Primary ID of Target Chain 41	UniProt (SwissProt) Secondary ID(s) of Target Chain 41	UniProt (SwissProt) Alternative ID(s) of Target Chain 41	UniProt (TrEMBL) Submitted Name of Target Chain 41	UniProt (TrEMBL) Entry Name of Target Chain 41	UniProt (TrEMBL) Primary ID of Target Chain 41	UniProt (TrEMBL) Secondary ID(s) of Target Chain 41	UniProt (TrEMBL) Alternative ID(s) of Target Chain 41	BindingDB Target Chain Sequence 42	PDB ID(s) of Target Chain 42	UniProt (SwissProt) Recommended Name of Target Chain 42	UniProt (SwissProt) Entry Name of Target Chain 42	UniProt (SwissProt) Primary ID of Target Chain 42	UniProt (SwissProt) Secondary ID(s) of Target Chain 42	UniProt (SwissProt) Alternative ID(s) of Target Chain 42	UniProt (TrEMBL) Submitted Name of Target Chain 42	UniProt (TrEMBL) Entry Name of Target Chain 42	UniProt (TrEMBL) Primary ID of Target Chain 42	UniProt (TrEMBL) Secondary ID(s) of Target Chain 42	UniProt (TrEMBL) Alternative ID(s) of Target Chain 42	BindingDB Target Chain Sequence 43	PDB ID(s) of Target Chain 43	UniProt (SwissProt) Recommended Name of Target Chain 43	UniProt (SwissProt) Entry Name of Target Chain 43	UniProt (SwissProt) Primary ID of Target Chain 43	UniProt (SwissProt) Secondary ID(s) of Target Chain 43	UniProt (SwissProt) Alternative ID(s) of Target Chain 43	UniProt (TrEMBL) Submitted Name of Target Chain 43	UniProt (TrEMBL) Entry Name of Target Chain 43	UniProt (TrEMBL) Primary ID of Target Chain 43	UniProt (TrEMBL) Secondary ID(s) of Target Chain 43	UniProt (TrEMBL) Alternative ID(s) of Target Chain 43	BindingDB Target Chain Sequence 44	PDB ID(s) of Target Chain 44	UniProt (SwissProt) Recommended Name of Target Chain 44	UniProt (SwissProt) Entry Name of Target Chain 44	UniProt (SwissProt) Primary ID of Target Chain 44	UniProt (SwissProt) Secondary ID(s) of Target Chain 44	UniProt (SwissProt) Alternative ID(s) of Target Chain 44	UniProt (TrEMBL) Submitted Name of Target Chain 44	UniProt (TrEMBL) Entry Name of Target Chain 44	UniProt (TrEMBL) Primary ID of Target Chain 44	UniProt (TrEMBL) Secondary ID(s) of Target Chain 44	UniProt (TrEMBL) Alternative ID(s) of Target Chain 44	BindingDB Target Chain Sequence 45	PDB ID(s) of Target Chain 45	UniProt (SwissProt) Recommended Name of Target Chain 45	UniProt (SwissProt) Entry Name of Target Chain 45	UniProt (SwissProt) Primary ID of Target Chain 45	UniProt (SwissProt) Secondary ID(s) of Target Chain 45	UniProt (SwissProt) Alternative ID(s) of Target Chain 45	UniProt (TrEMBL) Submitted Name of Target Chain 45	UniProt (TrEMBL) Entry Name of Target Chain 45	UniProt (TrEMBL) Primary ID of Target Chain 45	UniProt (TrEMBL) Secondary ID(s) of Target Chain 45	UniProt (TrEMBL) Alternative ID(s) of Target Chain 45	BindingDB Target Chain Sequence 46	PDB ID(s) of Target Chain 46	UniProt (SwissProt) Recommended Name of Target Chain 46	UniProt (SwissProt) Entry Name of Target Chain 46	UniProt (SwissProt) Primary ID of Target Chain 46	UniProt (SwissProt) Secondary ID(s) of Target Chain 46	UniProt (SwissProt) Alternative ID(s) of Target Chain 46	UniProt (TrEMBL) Submitted Name of Target Chain 46	UniProt (TrEMBL) Entry Name of Target Chain 46	UniProt (TrEMBL) Primary ID of Target Chain 46	UniProt (TrEMBL) Secondary ID(s) of Target Chain 46	UniProt (TrEMBL) Alternative ID(s) of Target Chain 46	BindingDB Target Chain Sequence 47	PDB ID(s) of Target Chain 47	UniProt (SwissProt) Recommended Name of Target Chain 47	UniProt (SwissProt) Entry Name of Target Chain 47	UniProt (SwissProt) Primary ID of Target Chain 47	UniProt (SwissProt) Secondary ID(s) of Target Chain 47	UniProt (SwissProt) Alternative ID(s) of Target Chain 47	UniProt (TrEMBL) Submitted Name of Target Chain 47	UniProt (TrEMBL) Entry Name of Target Chain 47	UniProt (TrEMBL) Primary ID of Target Chain 47	UniProt (TrEMBL) Secondary ID(s) of Target Chain 47	UniProt (TrEMBL) Alternative ID(s) of Target Chain 47	BindingDB Target Chain Sequence 48	PDB ID(s) of Target Chain 48	UniProt (SwissProt) Recommended Name of Target Chain 48	UniProt (SwissProt) Entry Name of Target Chain 48	UniProt (SwissProt) Primary ID of Target Chain 48	UniProt (SwissProt) Secondary ID(s) of Target Chain 48	UniProt (SwissProt) Alternative ID(s) of Target Chain 48	UniProt (TrEMBL) Submitted Name of Target Chain 48	UniProt (TrEMBL) Entry Name of Target Chain 48	UniProt (TrEMBL) Primary ID of Target Chain 48	UniProt (TrEMBL) Secondary ID(s) of Target Chain 48	UniProt (TrEMBL) Alternative ID(s) of Target Chain 48	BindingDB Target Chain Sequence 49	PDB ID(s) of Target Chain 49	UniProt (SwissProt) Recommended Name of Target Chain 49	UniProt (SwissProt) Entry Name of Target Chain 49	UniProt (SwissProt) Primary ID of Target Chain 49	UniProt (SwissProt) Secondary ID(s) of Target Chain 49	UniProt (SwissProt) Alternative ID(s) of Target Chain 49	UniProt (TrEMBL) Submitted Name of Target Chain 49	UniProt (TrEMBL) Entry Name of Target Chain 49	UniProt (TrEMBL) Primary ID of Target Chain 49	UniProt (TrEMBL) Secondary ID(s) of Target Chain 49	UniProt (TrEMBL) Alternative ID(s) of Target Chain 49	BindingDB Target Chain Sequence 50	PDB ID(s) of Target Chain 50	UniProt (SwissProt) Recommended Name of Target Chain 50	UniProt (SwissProt) Entry Name of Target Chain 50	UniProt (SwissProt) Primary ID of Target Chain 50	UniProt (SwissProt) Secondary ID(s) of Target Chain 50	UniProt (SwissProt) Alternative ID(s) of Target Chain 50	UniProt (TrEMBL) Submitted Name of Target Chain 50	UniProt (TrEMBL) Entry Name of Target Chain 50	UniProt (TrEMBL) Primary ID of Target Chain 50	UniProt (TrEMBL) Secondary ID(s) of Target Chain 50	UniProt (TrEMBL) Alternative ID(s) of Target Chain 50
1113427	C[C@@H]1CN(c2nc(ccc2C(=O)NS(=O)(=O)c2ccccc2)-n2ccc(OCCC3(CC3)C(F)(F)F)n2)C(C)(C)C1	InChI=1S/C28H32F3N5O4S/c1-19-17-26(2,3)35(18-19)24-21(25(37)34-41(38,39)20-7-5-4-6-8-20)9-10-22(32-24)36-15-11-23(33-36)40-16-14-27(12-13-27)28(29,30)31/h4-11,15,19H,12-14,16-18H2,1-3H3,(H,34,37)/t19-/m0/s1	IGEOJNMYRZUKIK-IBGZPJMESA-N	526464	US11186566, Compound 1::US11186566, Compound 17	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				<100					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526464	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526464&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134393443	463790102							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113428	C[C@H]1CN(c2nc(ccc2C(=O)NS(=O)(=O)c2ccccc2)-n2ccc(OCCC3(CC3)C(F)(F)F)n2)C(C)(C)C1	InChI=1S/C28H32F3N5O4S/c1-19-17-26(2,3)35(18-19)24-21(25(37)34-41(38,39)20-7-5-4-6-8-20)9-10-22(32-24)36-15-11-23(33-36)40-16-14-27(12-13-27)28(29,30)31/h4-11,15,19H,12-14,16-18H2,1-3H3,(H,34,37)/t19-/m1/s1	IGEOJNMYRZUKIK-LJQANCHMSA-N	526465	(R)&#151;N-(Phenylsulfonyl)-6-(3-(2-(1-(trifluoromethyl)cyclopropyl)ethoxy)-1H-pyrazol-1-yl)-2-(2,2,4-trimethylpyrrolidin-1-yl)nicotinamide::US11186566, Compound 2	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				 550					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526465	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526465&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134393472	463790103							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113429	COc1cc(ccc1O)S(=O)(=O)NC(=O)c1ccc(nc1Cl)-n1ccc(OCCC2(CC2)C(F)(F)F)n1	InChI=1S/C22H20ClF3N4O6S/c1-35-16-12-13(2-4-15(16)31)37(33,34)29-20(32)14-3-5-17(27-19(14)23)30-10-6-18(28-30)36-11-9-21(7-8-21)22(24,25)26/h2-6,10,12,31H,7-9,11H2,1H3,(H,29,32)	RNTVRXFQBOAFRA-UHFFFAOYSA-N	526466	(S)&#151;N-((4-Hydroxy-3-methoxyphenyl)sulfonyl)-6-(3-(2-(1-(trifluoromethyl)cyclopropyl)ethoxy)-1H-pyrazol-1-yl)-2-(2,2,4-trimethylpyrrolidin-1-yl)nicotinamide::US11186566, Compound 3	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				<100					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526466	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526466&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134393473	463790104							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113430	C[C@@H]1CN(c2nc(ccc2C(=O)NS(=O)(=O)c2ccccc2C)-n2ccc(OCCC3(CC3)C(F)(F)F)n2)C(C)(C)C1	InChI=1S/C29H34F3N5O4S/c1-19-17-27(3,4)36(18-19)25-21(26(38)35-42(39,40)22-8-6-5-7-20(22)2)9-10-23(33-25)37-15-11-24(34-37)41-16-14-28(12-13-28)29(30,31)32/h5-11,15,19H,12-14,16-18H2,1-4H3,(H,35,38)/t19-/m0/s1	PMPPQWGEEPJJOX-IBGZPJMESA-N	526467	US11186566, Compound 4	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				<100					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526467	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526467&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134393476	463790105							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113431	C[C@@H]1CN(c2nc(ccc2C(=O)NS(=O)(=O)c2cccc(F)c2)-n2ccc(OCCC3(CC3)C(F)(F)F)n2)C(C)(C)C1	InChI=1S/C28H31F4N5O4S/c1-18-16-26(2,3)36(17-18)24-21(25(38)35-42(39,40)20-6-4-5-19(29)15-20)7-8-22(33-24)37-13-9-23(34-37)41-14-12-27(10-11-27)28(30,31)32/h4-9,13,15,18H,10-12,14,16-17H2,1-3H3,(H,35,38)/t18-/m0/s1	DFLNZIUOSDIYMD-SFHVURJKSA-N	526468	US11186566, Compound 5	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				<100					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526468	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526468&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134393478	463790106							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113432	C[C@@H]1CN(c2nc(ccc2C(=O)NS(=O)(=O)c2ccccc2C)-n2ccc(OCC3C4(CC4)C33CC3)n2)C(C)(C)C1	InChI=1S/C31H37N5O4S/c1-20-17-29(3,4)35(18-20)27-22(28(37)34-41(38,39)23-8-6-5-7-21(23)2)9-10-25(32-27)36-16-11-26(33-36)40-19-24-30(12-13-30)31(24)14-15-31/h5-11,16,20,24H,12-15,17-19H2,1-4H3,(H,34,37)/t20-/m0/s1	PUMSXYFUJZKRQW-FQEVSTJZSA-N	526469	US11186566, Compound 8	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				<100					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526469	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526469&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134393482	463790107							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113433	CC1(C)CC(CO)CN1c1nc(ccc1C(=O)NS(=O)(=O)c1ccccc1)-n1ccc(OCCC2(CC2)C(F)(F)F)n1	InChI=1S/C28H32F3N5O5S/c1-26(2)16-19(18-37)17-35(26)24-21(25(38)34-42(39,40)20-6-4-3-5-7-20)8-9-22(32-24)36-14-10-23(33-36)41-15-13-27(11-12-27)28(29,30)31/h3-10,14,19,37H,11-13,15-18H2,1-2H3,(H,34,38)	RZZFHRZWOILSKA-UHFFFAOYSA-N	526470	US11186566, Compound 9	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				 550					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526470	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526470&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134393483	463790108							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113434	C[C@@H]1CN(c2nc(ccc2C(=O)NS(=O)(=O)c2ccccc2)-n2ccc(OCC3(CCC3)C(F)(F)F)n2)C(C)(C)C1	InChI=1S/C28H32F3N5O4S/c1-19-16-26(2,3)35(17-19)24-21(25(37)34-41(38,39)20-8-5-4-6-9-20)10-11-22(32-24)36-15-12-23(33-36)40-18-27(13-7-14-27)28(29,30)31/h4-6,8-12,15,19H,7,13-14,16-18H2,1-3H3,(H,34,37)/t19-/m0/s1	VOBJZDVBQBIDGT-IBGZPJMESA-N	526471	US11186566, Compound 10	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				<100					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526471	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526471&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134393695	463790109							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113435	C[C@@H]1CN(c2nc(ccc2C(=O)NS(=O)(=O)c2ccc(cc2C)C#N)-n2ccc(OCC3(CC3)C(F)(F)F)n2)C(C)(C)C1	InChI=1S/C29H31F3N6O4S/c1-18-14-27(3,4)37(16-18)25-21(26(39)36-43(40,41)22-7-5-20(15-33)13-19(22)2)6-8-23(34-25)38-12-9-24(35-38)42-17-28(10-11-28)29(30,31)32/h5-9,12-13,18H,10-11,14,16-17H2,1-4H3,(H,36,39)/t18-/m0/s1	SYLZVQRLFHESHC-SFHVURJKSA-N	526472	US11186566, Compound 11	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				 550					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526472	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526472&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134399497	463790110							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113436	COc1cc(C)ccc1S(=O)(=O)NC(=O)c1ccc(nc1N1C[C@@H](C)CC1(C)C)-n1ccc(OCC2(CC2)C(F)(F)F)n1	InChI=1S/C29H34F3N5O5S/c1-18-6-8-22(21(14-18)41-5)43(39,40)35-26(38)20-7-9-23(33-25(20)36-16-19(2)15-27(36,3)4)37-13-10-24(34-37)42-17-28(11-12-28)29(30,31)32/h6-10,13-14,19H,11-12,15-17H2,1-5H3,(H,35,38)/t19-/m0/s1	QMIUGTKXIOTTJQ-IBGZPJMESA-N	526473	US11186566, Compound 12	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				<100					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526473	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526473&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134399399	463790111							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113437	COc1ccc(c(OC)c1)S(=O)(=O)NC(=O)c1ccc(nc1N1C[C@@H](C)CC1(C)C)-n1ccc(OCC2(CC2)C(F)(F)F)n1	InChI=1S/C29H34F3N5O6S/c1-18-15-27(2,3)36(16-18)25-20(26(38)35-44(39,40)22-8-6-19(41-4)14-21(22)42-5)7-9-23(33-25)37-13-10-24(34-37)43-17-28(11-12-28)29(30,31)32/h6-10,13-14,18H,11-12,15-17H2,1-5H3,(H,35,38)/t18-/m0/s1	FRLLUAZJYAWRMP-SFHVURJKSA-N	526474	US11186566, Compound 13	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				 550					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526474	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526474&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134393701	463790112							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113438	C[C@@H]1CN(c2nc(ccc2C(=O)NS(=O)(=O)c2ccccc2)-n2ccc(OCC3(CC3)C(F)(F)F)n2)C(C)(C)C1	InChI=1S/C27H30F3N5O4S/c1-18-15-25(2,3)34(16-18)23-20(24(36)33-40(37,38)19-7-5-4-6-8-19)9-10-21(31-23)35-14-11-22(32-35)39-17-26(12-13-26)27(28,29)30/h4-11,14,18H,12-13,15-17H2,1-3H3,(H,33,36)/t18-/m0/s1	AQFQRBCAVCLKIF-SFHVURJKSA-N	526475	US11186566, Compound 14	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				<100					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526475	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526475&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134393502	463790113							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113439	C[C@@H]1CN(c2nc(ccc2C(=O)NS(=O)(=O)c2ccccc2C)-n2ccc(OCC3C(C)(C)C3(C)C)n2)C(C)(C)C1	InChI=1S/C31H41N5O4S/c1-20-17-29(3,4)35(18-20)27-22(28(37)34-41(38,39)23-12-10-9-11-21(23)2)13-14-25(32-27)36-16-15-26(33-36)40-19-24-30(5,6)31(24,7)8/h9-16,20,24H,17-19H2,1-8H3,(H,34,37)/t20-/m0/s1	VMFYHSOVOZEXTA-FQEVSTJZSA-N	526476	US11186566, Compound 15	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				<100					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526476	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526476&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134393503	463790114							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113440	C[C@@H]1CN(c2nc(ccc2C(=O)NS(=O)(=O)c2cccc(F)c2)-n2ccc(OCC3C(C)(C)C3(C)C)n2)C(C)(C)C1	InChI=1S/C30H38FN5O4S/c1-19-16-28(2,3)35(17-19)26-22(27(37)34-41(38,39)21-10-8-9-20(31)15-21)11-12-24(32-26)36-14-13-25(33-36)40-18-23-29(4,5)30(23,6)7/h8-15,19,23H,16-18H2,1-7H3,(H,34,37)/t19-/m0/s1	RLGCTZRCQJAVOU-IBGZPJMESA-N	526477	US11186566, Compound 16	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				<100					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526477	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526477&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134393510	463790115							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113441	C[C@@H]1CN(c2nc(ccc2C(=O)NS(=O)(=O)c2ccccc2)-n2ccc(OCCC3(CC3)C(F)(F)F)n2)C(C)(C)C1	InChI=1S/C28H32F3N5O4S/c1-19-17-26(2,3)35(18-19)24-21(25(37)34-41(38,39)20-7-5-4-6-8-20)9-10-22(32-24)36-15-11-23(33-36)40-16-14-27(12-13-27)28(29,30)31/h4-11,15,19H,12-14,16-18H2,1-3H3,(H,34,37)/t19-/m0/s1	IGEOJNMYRZUKIK-IBGZPJMESA-N	526464	US11186566, Compound 1::US11186566, Compound 17	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				<100					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526464	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526464&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134393443	463790102							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113442	C[C@@H]1CN(c2nc(ccc2C(=O)NS(=O)(=O)c2ccccc2)-n2ccc(O[C@H]3C[C@H]3C(F)(F)F)n2)C(C)(C)C1	InChI=1S/C26H28F3N5O4S/c1-16-14-25(2,3)33(15-16)23-18(24(35)32-39(36,37)17-7-5-4-6-8-17)9-10-21(30-23)34-12-11-22(31-34)38-20-13-19(20)26(27,28)29/h4-12,16,19-20H,13-15H2,1-3H3,(H,32,35)/t16-,19+,20-/m0/s1	MVPPCAISXBXBFU-DBVUQKKJSA-N	526479	US11186566, Compound 18	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				 550					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526479	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526479&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134393531	463790116							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113443	C[C@@H]1CN(c2nc(ccc2C(=O)NS(=O)(=O)c2ccccc2)-n2ccc(O[C@H]3C[C@@H]3C(F)(F)F)n2)C(C)(C)C1	InChI=1S/C26H28F3N5O4S/c1-16-14-25(2,3)33(15-16)23-18(24(35)32-39(36,37)17-7-5-4-6-8-17)9-10-21(30-23)34-12-11-22(31-34)38-20-13-19(20)26(27,28)29/h4-12,16,19-20H,13-15H2,1-3H3,(H,32,35)/t16-,19-,20-/m0/s1	MVPPCAISXBXBFU-VDGAXYAQSA-N	526480	US11186566, Compound 19	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				 550					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526480	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526480&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134393539	463790117							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113444	C[C@@H]1CN(c2nc(ccc2C(=O)NS(=O)(=O)c2ccccc2O)-n2ccc(OCC3(CC3)C(F)(F)F)n2)C(C)(C)C1	InChI=1S/C27H30F3N5O5S/c1-17-14-25(2,3)34(15-17)23-18(24(37)33-41(38,39)20-7-5-4-6-19(20)36)8-9-21(31-23)35-13-10-22(32-35)40-16-26(11-12-26)27(28,29)30/h4-10,13,17,36H,11-12,14-16H2,1-3H3,(H,33,37)/t17-/m0/s1	PCPBGPXORZUIGB-KRWDZBQOSA-N	526481	US11186566, Compound 20	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				 550					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526481	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526481&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134399438	463790118							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113445	C[C@@H]1CN(c2nc(ccc2C(=O)NS(=O)(=O)c2cccc(O)c2)-n2ccc(OCC3(CC3)C(F)(F)F)n2)C(C)(C)C1	InChI=1S/C27H30F3N5O5S/c1-17-14-25(2,3)34(15-17)23-20(24(37)33-41(38,39)19-6-4-5-18(36)13-19)7-8-21(31-23)35-12-9-22(32-35)40-16-26(10-11-26)27(28,29)30/h4-9,12-13,17,36H,10-11,14-16H2,1-3H3,(H,33,37)/t17-/m0/s1	FMVYNWXRQOTLFY-KRWDZBQOSA-N	526482	US11186566, Compound 21	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				<100					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526482	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526482&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134399398	463790119							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113446	C[C@@H]1CN(c2nc(ccc2C(=O)NS(=O)(=O)c2ccc(O)cc2)-n2ccc(OCC3(CC3)C(F)(F)F)n2)C(C)(C)C1	InChI=1S/C27H30F3N5O5S/c1-17-14-25(2,3)34(15-17)23-20(24(37)33-41(38,39)19-6-4-18(36)5-7-19)8-9-21(31-23)35-13-10-22(32-35)40-16-26(11-12-26)27(28,29)30/h4-10,13,17,36H,11-12,14-16H2,1-3H3,(H,33,37)/t17-/m0/s1	VMVXOUKCKHODNH-KRWDZBQOSA-N	526483	US11186566, Compound 22	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				 550					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526483	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526483&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134393704	463790120							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113447	C[C@@H]1CN(c2nc(ccc2C(=O)NS(=O)(=O)c2ccccc2C)-n2ccc(OCC3(CC3)C(F)(F)F)n2)C(C)(C)C1	InChI=1S/C28H32F3N5O4S/c1-18-15-26(3,4)35(16-18)24-20(25(37)34-41(38,39)21-8-6-5-7-19(21)2)9-10-22(32-24)36-14-11-23(33-36)40-17-27(12-13-27)28(29,30)31/h5-11,14,18H,12-13,15-17H2,1-4H3,(H,34,37)/t18-/m0/s1	XQIVSTROBCQVNB-SFHVURJKSA-N	526484	US11186566, Compound 23	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				<100					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526484	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526484&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134393691	463790121							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113448	C[C@@H]1CN(c2nc(ccc2C(=O)NS(=O)(=O)c2ccc(C)cc2)-n2ccc(OCC3(CC3)C(F)(F)F)n2)C(C)(C)C1	InChI=1S/C28H32F3N5O4S/c1-18-5-7-20(8-6-18)41(38,39)34-25(37)21-9-10-22(32-24(21)35-16-19(2)15-26(35,3)4)36-14-11-23(33-36)40-17-27(12-13-27)28(29,30)31/h5-11,14,19H,12-13,15-17H2,1-4H3,(H,34,37)/t19-/m0/s1	GJEHRZGUQNDWJG-IBGZPJMESA-N	526485	US11186566, Compound 24	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				<100					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526485	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526485&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134393699	463790122							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113449	C[C@@H]1CN(c2nc(ccc2C(=O)NS(=O)(=O)c2cccc(c2)C#N)-n2ccc(OCC3(CC3)C(F)(F)F)n2)C(C)(C)C1	InChI=1S/C28H29F3N6O4S/c1-18-14-26(2,3)36(16-18)24-21(25(38)35-42(39,40)20-6-4-5-19(13-20)15-32)7-8-22(33-24)37-12-9-23(34-37)41-17-27(10-11-27)28(29,30)31/h4-9,12-13,18H,10-11,14,16-17H2,1-3H3,(H,35,38)/t18-/m0/s1	KIRZNCYDNBTAEV-SFHVURJKSA-N	526486	US11186566, Compound 25	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				<100					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526486	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526486&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134399435	463790123							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113450	C[C@@H]1CN(c2nc(ccc2C(=O)NS(=O)(=O)c2ccccc2C#N)-n2ccc(OCC3(CC3)C(F)(F)F)n2)C(C)(C)C1	InChI=1S/C28H29F3N6O4S/c1-18-14-26(2,3)36(16-18)24-20(25(38)35-42(39,40)21-7-5-4-6-19(21)15-32)8-9-22(33-24)37-13-10-23(34-37)41-17-27(11-12-27)28(29,30)31/h4-10,13,18H,11-12,14,16-17H2,1-3H3,(H,35,38)/t18-/m0/s1	SSCKRTZVXTZHJO-SFHVURJKSA-N	526487	US11186566, Compound 26	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				>1000					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526487	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526487&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134399433	463790124							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113451	C[C@@H]1CN(c2nc(ccc2C(=O)NS(=O)(=O)c2ccc(cc2)C#N)-n2ccc(OCC3(CC3)C(F)(F)F)n2)C(C)(C)C1	InChI=1S/C28H29F3N6O4S/c1-18-14-26(2,3)36(16-18)24-21(25(38)35-42(39,40)20-6-4-19(15-32)5-7-20)8-9-22(33-24)37-13-10-23(34-37)41-17-27(11-12-27)28(29,30)31/h4-10,13,18H,11-12,14,16-17H2,1-3H3,(H,35,38)/t18-/m0/s1	DNBVDDUXBCUVLE-SFHVURJKSA-N	526488	US11186566, Compound 27	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				 550					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526488	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526488&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134393703	463790125							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113452	C[C@@H]1CN(c2nc(ccc2C(=O)NS(=O)(=O)c2cccc(C)c2)-n2ccc(OCC3(CC3)C(F)(F)F)n2)C(C)(C)C1	InChI=1S/C28H32F3N5O4S/c1-18-6-5-7-20(14-18)41(38,39)34-25(37)21-8-9-22(32-24(21)35-16-19(2)15-26(35,3)4)36-13-10-23(33-36)40-17-27(11-12-27)28(29,30)31/h5-10,13-14,19H,11-12,15-17H2,1-4H3,(H,34,37)/t19-/m0/s1	DIDRIGBBLXSNPE-IBGZPJMESA-N	526489	US11186566, Compound 28	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				<100					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526489	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526489&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134393693	463790126							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113453	C[C@@H]1CN(c2nc(ccc2C(=O)NS(=O)(=O)c2ccccc2)-n2ccc(COC3(C)CC3)n2)C(C)(C)C1	InChI=1S/C27H33N5O4S/c1-19-16-26(2,3)31(17-19)24-22(25(33)30-37(34,35)21-8-6-5-7-9-21)10-11-23(28-24)32-15-12-20(29-32)18-36-27(4)13-14-27/h5-12,15,19H,13-14,16-18H2,1-4H3,(H,30,33)/t19-/m0/s1	FJPUBSMBOLNKRB-IBGZPJMESA-N	526490	US11186566, Compound 29	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				 550					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526490	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526490&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134393567	463790127							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113454	C[C@@H]1CN(c2nc(ccc2C(=O)NS(=O)(=O)c2ccccc2)-n2ccc(OCC3C(C)(C)C3(C)C)n2)C(C)(C)C1	InChI=1S/C30H39N5O4S/c1-20-17-28(2,3)34(18-20)26-22(27(36)33-40(37,38)21-11-9-8-10-12-21)13-14-24(31-26)35-16-15-25(32-35)39-19-23-29(4,5)30(23,6)7/h8-16,20,23H,17-19H2,1-7H3,(H,33,36)/t20-/m0/s1	GOJWWVIQSAHVSB-FQEVSTJZSA-N	526491	US11186566, Compound 30::US11186566, Compound 36	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				<100					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526491	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526491&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134393569	463790128							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113455	C[C@@H]1CN(c2nc(ccc2C(=O)NS(=O)(=O)c2ccc(O)cc2)-n2ccc(OCCC3(CC3)C(F)(F)F)n2)C(C)(C)C1	InChI=1S/C28H32F3N5O5S/c1-18-16-26(2,3)35(17-18)24-21(25(38)34-42(39,40)20-6-4-19(37)5-7-20)8-9-22(32-24)36-14-10-23(33-36)41-15-13-27(11-12-27)28(29,30)31/h4-10,14,18,37H,11-13,15-17H2,1-3H3,(H,34,38)/t18-/m0/s1	NYQRAIZTYOMWDF-SFHVURJKSA-N	526492	US11186566, Compound 31	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				<100					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526492	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526492&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134393446	463790129							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113456	C[C@@H]1CN(c2nc(ccc2C(=O)NS(=O)(=O)c2ccccc2)-n2nc(OCCC3(CC3)C(F)(F)F)cc2F)C(C)(C)C1	InChI=1S/C28H31F4N5O4S/c1-18-16-26(2,3)36(17-18)24-20(25(38)35-42(39,40)19-7-5-4-6-8-19)9-10-22(33-24)37-21(29)15-23(34-37)41-14-13-27(11-12-27)28(30,31)32/h4-10,15,18H,11-14,16-17H2,1-3H3,(H,35,38)/t18-/m0/s1	RYEXNMQWIOOZOE-SFHVURJKSA-N	526493	US11186566, Compound 32	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				<100					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526493	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526493&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134393696	463790130							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113457	C[C@@H]1CN(c2nc(ccc2C(=O)NS(=O)(=O)c2ccc(O)cc2)-n2ccc(OCC3C(C)(C)C3(C)C)n2)C(C)(C)C1	InChI=1S/C30H39N5O5S/c1-19-16-28(2,3)34(17-19)26-22(27(37)33-41(38,39)21-10-8-20(36)9-11-21)12-13-24(31-26)35-15-14-25(32-35)40-18-23-29(4,5)30(23,6)7/h8-15,19,23,36H,16-18H2,1-7H3,(H,33,37)/t19-/m0/s1	OSQOAKLGZVVFDM-IBGZPJMESA-N	526494	US11186566, Compound 33	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				<100					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526494	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526494&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134393574	463790131							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113458	C[C@@H]1CN(c2nc(ccc2C(=O)NS(=O)(=O)c2ccccc2O)-n2ccc(OCCC3(CC3)C(F)(F)F)n2)C(C)(C)C1	InChI=1S/C28H32F3N5O5S/c1-18-16-26(2,3)35(17-18)24-19(25(38)34-42(39,40)21-7-5-4-6-20(21)37)8-9-22(32-24)36-14-10-23(33-36)41-15-13-27(11-12-27)28(29,30)31/h4-10,14,18,37H,11-13,15-17H2,1-3H3,(H,34,38)/t18-/m0/s1	JJLFVNOKYBZMPX-SFHVURJKSA-N	526495	US11186566, Compound 34	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				<100					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526495	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526495&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134393444	463790132							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113459	C[C@@H]1CN(c2nc(ccc2C(=O)NS(=O)(=O)c2cccc(O)c2)-n2ccc(OCCC3(CC3)C(F)(F)F)n2)C(C)(C)C1	InChI=1S/C28H32F3N5O5S/c1-18-16-26(2,3)35(17-18)24-21(25(38)34-42(39,40)20-6-4-5-19(37)15-20)7-8-22(32-24)36-13-9-23(33-36)41-14-12-27(10-11-27)28(29,30)31/h4-9,13,15,18,37H,10-12,14,16-17H2,1-3H3,(H,34,38)/t18-/m0/s1	ZXBDUJFWEFLISG-SFHVURJKSA-N	526496	US11186566, Compound 35	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				<100					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526496	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526496&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134393577	463790133							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113460	C[C@@H]1CN(c2nc(ccc2C(=O)NS(=O)(=O)c2ccccc2)-n2ccc(OCC3C(C)(C)C3(C)C)n2)C(C)(C)C1	InChI=1S/C30H39N5O4S/c1-20-17-28(2,3)34(18-20)26-22(27(36)33-40(37,38)21-11-9-8-10-12-21)13-14-24(31-26)35-16-15-25(32-35)39-19-23-29(4,5)30(23,6)7/h8-16,20,23H,17-19H2,1-7H3,(H,33,36)/t20-/m0/s1	GOJWWVIQSAHVSB-FQEVSTJZSA-N	526491	US11186566, Compound 30::US11186566, Compound 36	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				<100					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526491	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526491&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134393569	463790128							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113461	C[C@@H]1CN(c2nc(ccc2C(=O)NS(=O)(=O)c2ccccc2)-n2ccc(COCC3(CC3)C(F)(F)F)n2)C(C)(C)C1	InChI=1S/C28H32F3N5O4S/c1-19-15-26(2,3)35(16-19)24-22(25(37)34-41(38,39)21-7-5-4-6-8-21)9-10-23(32-24)36-14-11-20(33-36)17-40-18-27(12-13-27)28(29,30)31/h4-11,14,19H,12-13,15-18H2,1-3H3,(H,34,37)/t19-/m0/s1	GYQTXCNCGVCKPK-IBGZPJMESA-N	526498	US11186566, Compound 37	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				<100					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526498	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526498&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134393584	463790134							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113462	C[C@@H]1CN(c2nc(ccc2C(=O)NS(=O)(=O)c2ccccc2)-n2ccc(OCC(O)C3(CC3)C(F)(F)F)n2)C(C)(C)C1	InChI=1S/C28H32F3N5O5S/c1-18-15-26(2,3)35(16-18)24-20(25(38)34-42(39,40)19-7-5-4-6-8-19)9-10-22(32-24)36-14-11-23(33-36)41-17-21(37)27(12-13-27)28(29,30)31/h4-11,14,18,21,37H,12-13,15-17H2,1-3H3,(H,34,38)/t18-,21?/m0/s1	POALNAGCDOIXGU-YMXDCFFPSA-N	526499	US11186566, Compound 38	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				 550					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526499	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526499&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134393447	463790135							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113463	C[C@@H]1CN(c2nc(ccc2C(=O)NS(=O)(=O)c2ccccc2)-n2ccc(O[C@H]3C[C@H]4CC[C@@H]3C4)n2)C(C)(C)C1	InChI=1S/C29H35N5O4S/c1-19-17-29(2,3)33(18-19)27-23(28(35)32-39(36,37)22-7-5-4-6-8-22)11-12-25(30-27)34-14-13-26(31-34)38-24-16-20-9-10-21(24)15-20/h4-8,11-14,19-21,24H,9-10,15-18H2,1-3H3,(H,32,35)/t19-,20-,21+,24-/m0/s1	GQAUQTVFUGMNKL-JCUDRXCFSA-N	526500	US11186566, Compound 39	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				<100					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526500	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526500&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134393597	463790136							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113464	C[C@@H]1CN(c2nc(ccc2C(=O)NS(=O)(=O)c2ccccc2)-n2ccc(OCC3C[C@@H]4CC[C@@H]3C4)n2)C(C)(C)C1	InChI=1S/C30H37N5O4S/c1-20-17-30(2,3)34(18-20)28-25(29(36)33-40(37,38)24-7-5-4-6-8-24)11-12-26(31-28)35-14-13-27(32-35)39-19-23-16-21-9-10-22(23)15-21/h4-8,11-14,20-23H,9-10,15-19H2,1-3H3,(H,33,36)/t20-,21+,22+,23?/m0/s1	DTQWKWKBVCMSDS-PZKXETHGSA-N	526501	US11186566, Compound 40	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				<100					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526501	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526501&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134393702	463790137							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113465	C[C@@H]1CN(c2nc(ccc2C(=O)NS(=O)(=O)c2ccccc2)-n2ccc(OCC(C3CC3)C3CC3)n2)C(C)(C)C1	InChI=1S/C30H37N5O4S/c1-20-17-30(2,3)34(18-20)28-24(29(36)33-40(37,38)23-7-5-4-6-8-23)13-14-26(31-28)35-16-15-27(32-35)39-19-25(21-9-10-21)22-11-12-22/h4-8,13-16,20-22,25H,9-12,17-19H2,1-3H3,(H,33,36)/t20-/m0/s1	WVFYUIWSILSHHL-FQEVSTJZSA-N	526502	US11186566, Compound 41	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				<100					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526502	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526502&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134393608	463790138							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113466	C[C@@H]1CN(c2nc(ccc2C(=O)NS(=O)(=O)c2ccccc2)-n2ccc(OCCC(C3CC3)C3CC3)n2)C(C)(C)C1	InChI=1S/C31H39N5O4S/c1-21-19-31(2,3)35(20-21)29-26(30(37)34-41(38,39)24-7-5-4-6-8-24)13-14-27(32-29)36-17-15-28(33-36)40-18-16-25(22-9-10-22)23-11-12-23/h4-8,13-15,17,21-23,25H,9-12,16,18-20H2,1-3H3,(H,34,37)/t21-/m0/s1	RLNQVOHHZYRBIX-NRFANRHFSA-N	526503	US11186566, Compound 42	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				<100					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526503	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526503&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134393616	463790139							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113467	C[C@@H]1CN(c2nc(ccc2C(=O)NS(=O)(=O)c2ccccc2Cl)-n2ccc(OCCC3(CC3)C(F)(F)F)n2)C(C)(C)C1	InChI=1S/C28H31ClF3N5O4S/c1-18-16-26(2,3)36(17-18)24-19(25(38)35-42(39,40)21-7-5-4-6-20(21)29)8-9-22(33-24)37-14-10-23(34-37)41-15-13-27(11-12-27)28(30,31)32/h4-10,14,18H,11-13,15-17H2,1-3H3,(H,35,38)/t18-/m0/s1	HWRRKFSXPSUGLD-SFHVURJKSA-N	526504	US11186566, Compound 43	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				<100					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526504	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526504&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134393618	463790140							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113468	C[C@@H]1CN(c2cc(ncc2C(=O)NS(=O)(=O)c2ccccc2)-n2ccc(OCCC3(CC3)C(F)(F)F)n2)C(C)(C)C1	InChI=1S/C28H32F3N5O4S/c1-19-16-26(2,3)35(18-19)22-15-23(32-17-21(22)25(37)34-41(38,39)20-7-5-4-6-8-20)36-13-9-24(33-36)40-14-12-27(10-11-27)28(29,30)31/h4-9,13,15,17,19H,10-12,14,16,18H2,1-3H3,(H,34,37)/t19-/m0/s1	CSWLBFSSPPIMRB-IBGZPJMESA-N	526505	US11186566, Compound 44	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				 550					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526505	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526505&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134393622	463790141							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113469	C[C@@H]1CN(c2nc(ccc2C(=O)NS(=N)(=O)c2ccccc2)-n2ccc(OCC3(CC3)C(F)(F)F)n2)C(C)(C)C1	InChI=1S/C27H31F3N6O3S/c1-18-15-25(2,3)35(16-18)23-20(24(37)34-40(31,38)19-7-5-4-6-8-19)9-10-21(32-23)36-14-11-22(33-36)39-17-26(12-13-26)27(28,29)30/h4-11,14,18H,12-13,15-17H2,1-3H3,(H2,31,34,37,38)/t18-,40?/m0/s1	ZLGHYAHBLMLYMV-YRNAOGQISA-N	526506	US11186566, Compound 45	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				 550					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526506	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526506&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			163199940	463790142							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113470	C[C@@H]1CN(c2nc(ccc2C(=O)NS(N)(=O)c2ccccc2)-n2ccc(OCC3(CC3)C(F)(F)F)n2)C(C)(C)C1	InChI=1S/C27H33F3N6O3S/c1-18-15-25(2,3)35(16-18)23-20(24(37)34-40(31,38)19-7-5-4-6-8-19)9-10-21(32-23)36-14-11-22(33-36)39-17-26(12-13-26)27(28,29)30/h4-11,14,18,40H,12-13,15-17H2,1-3H3,(H3,31,34,37,38)/t18-/m0/s1	YRMUWYMRSIDZRL-SFHVURJKSA-N	526507	US11186566, Compound 46	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				<100					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526507	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526507&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			163199940	463790143							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113471	C[C@@H]1CN(c2nc(ccc2C(=O)N[S@](=N)(=O)c2ccccc2)-n2ccc(OCC3(CC3)C(F)(F)F)n2)C(C)(C)C1	InChI=1S/C27H31F3N6O3S/c1-18-15-25(2,3)35(16-18)23-20(24(37)34-40(31,38)19-7-5-4-6-8-19)9-10-21(32-23)36-14-11-22(33-36)39-17-26(12-13-26)27(28,29)30/h4-11,14,18H,12-13,15-17H2,1-3H3,(H2,31,34,37,38)/t18-,40-/m0/s1	ZLGHYAHBLMLYMV-JSDMUQKJSA-N	526508	US11186566, Compound 47	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				<100					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526508	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526508&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search											1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113472	C[C@@H]1CN(c2nc(ccc2C(=O)NS(=O)(=O)c2ccccc2)-n2ccc(OC3CC3)n2)C(C)(C)C1	InChI=1S/C25H29N5O4S/c1-17-15-25(2,3)29(16-17)23-20(24(31)28-35(32,33)19-7-5-4-6-8-19)11-12-21(26-23)30-14-13-22(27-30)34-18-9-10-18/h4-8,11-14,17-18H,9-10,15-16H2,1-3H3,(H,28,31)/t17-/m0/s1	KIMYRSKRIZRNAD-KRWDZBQOSA-N	526509	US11186566, Compound 48	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				>1000					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526509	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526509&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134393635	463790144							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113473	COc1cccc(c1)S(=O)(=O)NC(=O)c1ccc(nc1N1C[C@@H](C)CC1(C)C)-n1ccc(OCC2(CC2)C(F)(F)F)n1	InChI=1S/C28H32F3N5O5S/c1-18-15-26(2,3)35(16-18)24-21(25(37)34-42(38,39)20-7-5-6-19(14-20)40-4)8-9-22(32-24)36-13-10-23(33-36)41-17-27(11-12-27)28(29,30)31/h5-10,13-14,18H,11-12,15-17H2,1-4H3,(H,34,37)/t18-/m0/s1	IAICSRKZVDRUMC-SFHVURJKSA-N	526510	US11186566, Compound 49	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				<100					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526510	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526510&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134393688	463790145							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113474	C[C@@H]1CN(c2nc(ccc2C(=O)NS(=O)(=O)c2ccccc2F)-n2ccc(OCC3(CC3)C(F)(F)F)n2)C(C)(C)C1	InChI=1S/C27H29F4N5O4S/c1-17-14-25(2,3)35(15-17)23-18(24(37)34-41(38,39)20-7-5-4-6-19(20)28)8-9-21(32-23)36-13-10-22(33-36)40-16-26(11-12-26)27(29,30)31/h4-10,13,17H,11-12,14-16H2,1-3H3,(H,34,37)/t17-/m0/s1	PVJXZHDNFHUPCF-KRWDZBQOSA-N	526511	US11186566, Compound 50	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				<100					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526511	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526511&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134393690	463790146							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113475	C[C@@H]1CN(c2nc(ccc2C(=O)NS(=O)(=O)c2cccc(F)c2)-n2ccc(OCC3(CC3)C(F)(F)F)n2)C(C)(C)C1	InChI=1S/C27H29F4N5O4S/c1-17-14-25(2,3)35(15-17)23-20(24(37)34-41(38,39)19-6-4-5-18(28)13-19)7-8-21(32-23)36-12-9-22(33-36)40-16-26(10-11-26)27(29,30)31/h4-9,12-13,17H,10-11,14-16H2,1-3H3,(H,34,37)/t17-/m0/s1	VBYWIASXKMBLHM-KRWDZBQOSA-N	526512	US11186566, Compound 51	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				<100					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526512	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526512&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134393697	463790147							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113476	C[C@@H]1CN(c2nc(ccc2C(=O)NS(=O)(=O)c2ccc(F)cc2)-n2ccc(OCC3(CC3)C(F)(F)F)n2)C(C)(C)C1	InChI=1S/C27H29F4N5O4S/c1-17-14-25(2,3)35(15-17)23-20(24(37)34-41(38,39)19-6-4-18(28)5-7-19)8-9-21(32-23)36-13-10-22(33-36)40-16-26(11-12-26)27(29,30)31/h4-10,13,17H,11-12,14-16H2,1-3H3,(H,34,37)/t17-/m0/s1	OHANNRGPDGTRRB-KRWDZBQOSA-N	526513	US11186566, Compound 52	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				<100					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526513	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526513&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134399513	463790148							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113477	COc1ccccc1S(=O)(=O)NC(=O)c1ccc(nc1N1C[C@@H](C)CC1(C)C)-n1ccc(OCC2(CC2)C(F)(F)F)n1	InChI=1S/C28H32F3N5O5S/c1-18-15-26(2,3)35(16-18)24-19(25(37)34-42(38,39)21-8-6-5-7-20(21)40-4)9-10-22(32-24)36-14-11-23(33-36)41-17-27(12-13-27)28(29,30)31/h5-11,14,18H,12-13,15-17H2,1-4H3,(H,34,37)/t18-/m0/s1	GHASNKRJUHCHNZ-SFHVURJKSA-N	526514	US11186566, Compound 53	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				<100					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526514	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526514&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134393694	463790149							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113478	COc1ccc(cc1)S(=O)(=O)NC(=O)c1ccc(nc1N1C[C@@H](C)CC1(C)C)-n1ccc(OCC2(CC2)C(F)(F)F)n1	InChI=1S/C28H32F3N5O5S/c1-18-15-26(2,3)35(16-18)24-21(25(37)34-42(38,39)20-7-5-19(40-4)6-8-20)9-10-22(32-24)36-14-11-23(33-36)41-17-27(12-13-27)28(29,30)31/h5-11,14,18H,12-13,15-17H2,1-4H3,(H,34,37)/t18-/m0/s1	ZDLUKUPLYJQBFK-SFHVURJKSA-N	526515	US11186566, Compound 54	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				<100					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526515	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526515&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134399514	463790150							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113479	C[C@@H]1CN(c2nc(ccc2C(=O)NS(=O)(=O)c2ccccc2)-n2ccc(OCC3(CC3)C(F)F)n2)C(C)(C)C1	InChI=1S/C27H31F2N5O4S/c1-18-15-26(2,3)33(16-18)23-20(24(35)32-39(36,37)19-7-5-4-6-8-19)9-10-21(30-23)34-14-11-22(31-34)38-17-27(12-13-27)25(28)29/h4-11,14,18,25H,12-13,15-17H2,1-3H3,(H,32,35)/t18-/m0/s1	JSWYUNXPDUYODY-SFHVURJKSA-N	526516	US11186566, Compound 55	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				<100					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526516	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526516&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134393655	463790151							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113480	CC1(C)CN(c2nc(ccc2C(=O)NS(=O)(=O)c2ccccc2)-n2ccc(OCC3(CC3)C(F)(F)F)n2)C(C)(C)C1	InChI=1S/C28H32F3N5O4S/c1-25(2)16-26(3,4)35(17-25)23-20(24(37)34-41(38,39)19-8-6-5-7-9-19)10-11-21(32-23)36-15-12-22(33-36)40-18-27(13-14-27)28(29,30)31/h5-12,15H,13-14,16-18H2,1-4H3,(H,34,37)	XYENWMOSXPHBOT-UHFFFAOYSA-N	526517	US11186566, Compound 56	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				 550					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526517	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526517&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134393656	463790152							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113481	COc1ccc(c(C)c1)S(=O)(=O)NC(=O)c1ccc(nc1N1C[C@@H](C)CC1(C)C)-n1ccc(OCC2(CC2)C(F)(F)F)n1	InChI=1S/C29H34F3N5O5S/c1-18-15-27(3,4)36(16-18)25-21(26(38)35-43(39,40)22-8-6-20(41-5)14-19(22)2)7-9-23(33-25)37-13-10-24(34-37)42-17-28(11-12-28)29(30,31)32/h6-10,13-14,18H,11-12,15-17H2,1-5H3,(H,35,38)/t18-/m0/s1	PJXGOUOTBLFYPP-SFHVURJKSA-N	526518	US11186566, Compound 57	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				<100					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526518	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526518&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134393700	463790153							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113482	C[C@@H]1CN(c2nc(ccc2C(=O)NS(=O)(=O)c2ccccc2C)-n2ccc(OCC3(CCC3)C(F)(F)F)n2)C(C)(C)C1	InChI=1S/C29H34F3N5O4S/c1-19-16-27(3,4)36(17-19)25-21(26(38)35-42(39,40)22-9-6-5-8-20(22)2)10-11-23(33-25)37-15-12-24(34-37)41-18-28(13-7-14-28)29(30,31)32/h5-6,8-12,15,19H,7,13-14,16-18H2,1-4H3,(H,35,38)/t19-/m0/s1	XQRPBALBOHJZSL-IBGZPJMESA-N	526519	US11186566, Compound 58	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				<100					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526519	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526519&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134393698	463790154							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113483	C[C@@H]1CN(c2nc(ccc2C(=O)NS(=O)(=O)c2cccc(F)c2)-n2ccc(OCC3(CCC3)C(F)(F)F)n2)C(C)(C)C1	InChI=1S/C28H31F4N5O4S/c1-18-15-26(2,3)36(16-18)24-21(25(38)35-42(39,40)20-7-4-6-19(29)14-20)8-9-22(33-24)37-13-10-23(34-37)41-17-27(11-5-12-27)28(30,31)32/h4,6-10,13-14,18H,5,11-12,15-17H2,1-3H3,(H,35,38)/t18-/m0/s1	KAGKPLUFQLALLA-SFHVURJKSA-N	526520	US11186566, Compound 59	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				<100					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526520	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526520&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134399570	463790155							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113484	C[C@@H]1CN(c2nc(ccc2C(=O)NS(=O)(=O)c2ccccc2)-n2ccc(OCC3CC33CC3)n2)C(C)(C)C1	InChI=1S/C28H33N5O4S/c1-19-15-27(2,3)32(17-19)25-22(26(34)31-38(35,36)21-7-5-4-6-8-21)9-10-23(29-25)33-14-11-24(30-33)37-18-20-16-28(20)12-13-28/h4-11,14,19-20H,12-13,15-18H2,1-3H3,(H,31,34)/t19-,20?/m0/s1	YFIGQWCECKAEEX-XJDOXCRVSA-N	526521	US11186566, Compound 60	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				 550					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526521	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526521&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134393668	463790156							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113485	C[C@H]1CC(C)(C)N2C1OC(=O)c1ccc(nc21)-n1ccc(OCCC2(CC2)C(F)(F)F)n1	InChI=1S/C22H25F3N4O3/c1-13-12-20(2,3)29-17-14(19(30)32-18(13)29)4-5-15(26-17)28-10-6-16(27-28)31-11-9-21(7-8-21)22(23,24)25/h4-6,10,13,18H,7-9,11-12H2,1-3H3/t13-,18?/m0/s1	BHKIXXMUVIDDSH-FVRDMJKUSA-N	526522	US11186566, Compound 62	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				>1000					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526522	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526522&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134393450	463790157							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113486	C[C@@H]1CN(c2nc(ccc2C(=O)NS(=O)(=O)c2ccccc2)-n2ccc(OCC3C4(CC4)C33CC3)n2)C(C)(C)C1	InChI=1S/C30H35N5O4S/c1-20-17-28(2,3)34(18-20)26-22(27(36)33-40(37,38)21-7-5-4-6-8-21)9-10-24(31-26)35-16-11-25(32-35)39-19-23-29(12-13-29)30(23)14-15-30/h4-11,16,20,23H,12-15,17-19H2,1-3H3,(H,33,36)/t20-/m0/s1	IDAVUDFCPPOLFJ-FQEVSTJZSA-N	526523	US11186566, Compound 63::US11186566, Compound 64	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				 550					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526523	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526523&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134393681	463790158							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113487	C[C@@H]1CN(c2nc(ccc2C(=O)NS(=O)(=O)c2ccccc2)-n2ccc(OCC3C4(CC4)C33CC3)n2)C(C)(C)C1	InChI=1S/C30H35N5O4S/c1-20-17-28(2,3)34(18-20)26-22(27(36)33-40(37,38)21-7-5-4-6-8-21)9-10-24(31-26)35-16-11-25(32-35)39-19-23-29(12-13-29)30(23)14-15-30/h4-11,16,20,23H,12-15,17-19H2,1-3H3,(H,33,36)/t20-/m0/s1	IDAVUDFCPPOLFJ-FQEVSTJZSA-N	526523	US11186566, Compound 63::US11186566, Compound 64	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				<100					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526523	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526523&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134393681	463790158							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113488	C[C@@H]1CN(c2nc(ccc2C(=O)NS(=O)(=O)c2ccccc2)-n2ccc(O)n2)C(C)(C)C1	InChI=1S/C22H25N5O4S/c1-15-13-22(2,3)26(14-15)20-17(9-10-18(23-20)27-12-11-19(28)24-27)21(29)25-32(30,31)16-7-5-4-6-8-16/h4-12,15H,13-14H2,1-3H3,(H,24,28)(H,25,29)/t15-/m0/s1	WFKXOOSMWIGPOO-HNNXBMFYSA-N	526525	US11186566, Compound 65	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				>1000					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526525	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526525&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134393449	463790159							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113489	C[C@@H]1CN(c2nc(ccc2C(=O)NS(=O)(=O)c2cccnc2N)-n2ccc(OCC(C)(C)C)n2)C(C)(C)C1	InChI=1S/C26H35N7O4S/c1-17-14-26(5,6)32(15-17)23-18(24(34)31-38(35,36)19-8-7-12-28-22(19)27)9-10-20(29-23)33-13-11-21(30-33)37-16-25(2,3)4/h7-13,17H,14-16H2,1-6H3,(H2,27,28)(H,31,34)/t17-/m0/s1	URQRGAPWBNNFET-KRWDZBQOSA-N	526526	US11186566, Compound A	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				 60.0					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526526	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526526&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			121252495	463790160							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113490	C[C@@H]1CN(c2nc(ccc2C(=O)NS(=O)(=O)c2ccccc2)-n2ccc(OCC(C)(C)C)n2)C(C)(C)C1	InChI=1S/C27H35N5O4S/c1-19-16-27(5,6)31(17-19)24-21(25(33)30-37(34,35)20-10-8-7-9-11-20)12-13-22(28-24)32-15-14-23(29-32)36-18-26(2,3)4/h7-15,19H,16-18H2,1-6H3,(H,30,33)/t19-/m0/s1	OOOIQVABQGRAAD-IBGZPJMESA-N	526527	US11186566, Compound B	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				 120					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526527	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526527&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			121251726	463790161							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113491	C[C@@H]1CN(c2nc(ccc2C(=O)NS(=O)(=O)c2ccc[nH]c2=O)-n2ccc(OCC(C)(C)C)n2)C(C)(C)C1			526528	US11186566, Compound C	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				 260					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526528	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526528&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			163199941	463790162							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113492	C[C@@H]1CN(c2nc(ccc2C(=O)NS(=O)(=O)c2cccnc2N)-n2ccc(OCC3CC3)n2)C(C)(C)C1	InChI=1S/C25H31N7O4S/c1-16-13-25(2,3)31(14-16)23-18(24(33)30-37(34,35)19-5-4-11-27-22(19)26)8-9-20(28-23)32-12-10-21(29-32)36-15-17-6-7-17/h4-5,8-12,16-17H,6-7,13-15H2,1-3H3,(H2,26,27)(H,30,33)/t16-/m0/s1	DALJJRHMANUTKT-INIZCTEOSA-N	526529	US11186566, Compound D	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				 400					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526529	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526529&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			121253176	463790163							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113493	C[C@@H]1CN(c2nc(ccc2C(=O)NS(=O)(=O)c2cccnc2N)-n2ccc(OCC3CCC3)n2)C(C)(C)C1	InChI=1S/C26H33N7O4S/c1-17-14-26(2,3)32(15-17)24-19(25(34)31-38(35,36)20-8-5-12-28-23(20)27)9-10-21(29-24)33-13-11-22(30-33)37-16-18-6-4-7-18/h5,8-13,17-18H,4,6-7,14-16H2,1-3H3,(H2,27,28)(H,31,34)/t17-/m0/s1	RYQXWUGYDCKNJG-KRWDZBQOSA-N	526530	US11186566, Compound E	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				 210					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526530	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526530&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			121252894	463790164							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113494	COc1cccc(c1)S(=O)(=O)NC(=O)c1ccc(nc1N1C[C@@H](C)CC1(C)C)-n1ccc(OCC2(CC2)C(F)(F)F)n1	InChI=1S/C28H32F3N5O5S/c1-18-15-26(2,3)35(16-18)24-21(25(37)34-42(38,39)20-7-5-6-19(14-20)40-4)8-9-22(32-24)36-13-10-23(33-36)41-17-27(11-12-27)28(29,30)31/h5-10,13-14,18H,11-12,15-17H2,1-4H3,(H,34,37)/t18-/m0/s1	IAICSRKZVDRUMC-SFHVURJKSA-N	526510	US11186566, Compound 49	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				 20.0					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526510	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526510&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134393688	463790145							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113495	C[C@@H]1CN(c2nc(ccc2C(=O)NS(=O)(=O)c2ccccc2C)-n2ccc(OCCC3(CC3)C(F)(F)F)n2)C(C)(C)C1	InChI=1S/C29H34F3N5O4S/c1-19-17-27(3,4)36(18-19)25-21(26(38)35-42(39,40)22-8-6-5-7-20(22)2)9-10-23(33-25)37-15-11-24(34-37)41-16-14-28(12-13-28)29(30,31)32/h5-11,15,19H,12-14,16-18H2,1-4H3,(H,35,38)/t19-/m0/s1	PMPPQWGEEPJJOX-IBGZPJMESA-N	526467	US11186566, Compound 4	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				 20.0					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526467	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526467&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134393476	463790105							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113496	C[C@@H]1CN(c2nc(ccc2C(=O)NS(=O)(=O)c2ccccc2C)-n2ccc(OCC3C(C)(C)C3(C)C)n2)C(C)(C)C1	InChI=1S/C31H41N5O4S/c1-20-17-29(3,4)35(18-20)27-22(28(37)34-41(38,39)23-12-10-9-11-21(23)2)13-14-25(32-27)36-16-15-26(33-36)40-19-24-30(5,6)31(24,7)8/h9-16,20,24H,17-19H2,1-8H3,(H,34,37)/t20-/m0/s1	VMFYHSOVOZEXTA-FQEVSTJZSA-N	526476	US11186566, Compound 15	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				 20.0					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526476	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526476&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134393503	463790114							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113497	C[C@@H]1CN(c2nc(ccc2C(=O)NS(=O)(=O)c2cccc(F)c2)-n2ccc(OCC3C(C)(C)C3(C)C)n2)C(C)(C)C1	InChI=1S/C30H38FN5O4S/c1-19-16-28(2,3)35(17-19)26-22(27(37)34-41(38,39)21-10-8-9-20(31)15-21)11-12-24(32-26)36-14-13-25(33-36)40-18-23-29(4,5)30(23,6)7/h8-15,19,23H,16-18H2,1-7H3,(H,34,37)/t19-/m0/s1	RLGCTZRCQJAVOU-IBGZPJMESA-N	526477	US11186566, Compound 16	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				 20.0					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526477	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526477&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134393510	463790115							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113498	C[C@@H]1CN(c2nc(ccc2C(=O)NS(=O)(=O)c2ccccc2)-n2ccc(OCCC3(CC3)C(F)(F)F)n2)C(C)(C)C1	InChI=1S/C28H32F3N5O4S/c1-19-17-26(2,3)35(18-19)24-21(25(37)34-41(38,39)20-7-5-4-6-8-20)9-10-22(32-24)36-15-11-23(33-36)40-16-14-27(12-13-27)28(29,30)31/h4-11,15,19H,12-14,16-18H2,1-3H3,(H,34,37)/t19-/m0/s1	IGEOJNMYRZUKIK-IBGZPJMESA-N	526464	US11186566, Compound 1::US11186566, Compound 17	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				 30.0					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526464	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526464&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134393443	463790102							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113499	C[C@@H]1CN(c2nc(ccc2C(=O)NS(=O)(=O)c2ccccc2F)-n2ccc(OCC3(CC3)C(F)(F)F)n2)C(C)(C)C1	InChI=1S/C27H29F4N5O4S/c1-17-14-25(2,3)35(15-17)23-18(24(37)34-41(38,39)20-7-5-4-6-19(20)28)8-9-21(32-23)36-13-10-22(33-36)40-16-26(11-12-26)27(29,30)31/h4-10,13,17H,11-12,14-16H2,1-3H3,(H,34,37)/t17-/m0/s1	PVJXZHDNFHUPCF-KRWDZBQOSA-N	526511	US11186566, Compound 50	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				 30.0					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526511	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526511&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134393690	463790146							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113500	C[C@@H]1CN(c2nc(ccc2C(=O)NS(=O)(=O)c2ccccc2C)-n2ccc(OCC3(CC3)C(F)(F)F)n2)C(C)(C)C1	InChI=1S/C28H32F3N5O4S/c1-18-15-26(3,4)35(16-18)24-20(25(37)34-41(38,39)21-8-6-5-7-19(21)2)9-10-22(32-24)36-14-11-23(33-36)40-17-27(12-13-27)28(29,30)31/h5-11,14,18H,12-13,15-17H2,1-4H3,(H,34,37)/t18-/m0/s1	XQIVSTROBCQVNB-SFHVURJKSA-N	526484	US11186566, Compound 23	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				 30.0					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526484	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526484&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134393691	463790121							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113501	C[C@@H]1CN(c2nc(ccc2C(=O)NS(=O)(=O)c2cccc(C)c2)-n2ccc(OCC3(CC3)C(F)(F)F)n2)C(C)(C)C1	InChI=1S/C28H32F3N5O4S/c1-18-6-5-7-20(14-18)41(38,39)34-25(37)21-8-9-22(32-24(21)35-16-19(2)15-26(35,3)4)36-13-10-23(33-36)40-17-27(11-12-27)28(29,30)31/h5-10,13-14,19H,11-12,15-17H2,1-4H3,(H,34,37)/t19-/m0/s1	DIDRIGBBLXSNPE-IBGZPJMESA-N	526489	US11186566, Compound 28	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				 30.0					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526489	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526489&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134393693	463790126							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113502	C[C@@H]1CN(c2nc(ccc2C(=O)NS(=O)(=O)c2ccc(O)cc2)-n2ccc(OCCC3(CC3)C(F)(F)F)n2)C(C)(C)C1	InChI=1S/C28H32F3N5O5S/c1-18-16-26(2,3)35(17-18)24-21(25(38)34-42(39,40)20-6-4-19(37)5-7-20)8-9-22(32-24)36-14-10-23(33-36)41-15-13-27(11-12-27)28(29,30)31/h4-10,14,18,37H,11-13,15-17H2,1-3H3,(H,34,38)/t18-/m0/s1	NYQRAIZTYOMWDF-SFHVURJKSA-N	526492	US11186566, Compound 31	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				 30.0					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526492	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526492&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134393446	463790129							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113503	C[C@@H]1CN(c2nc(ccc2C(=O)NS(=O)(=O)c2ccccc2)-n2ccc(OCC3(CC3)C(F)(F)F)n2)C(C)(C)C1	InChI=1S/C27H30F3N5O4S/c1-18-15-25(2,3)34(16-18)23-20(24(36)33-40(37,38)19-7-5-4-6-8-19)9-10-21(31-23)35-14-11-22(32-35)39-17-26(12-13-26)27(28,29)30/h4-11,14,18H,12-13,15-17H2,1-3H3,(H,33,36)/t18-/m0/s1	AQFQRBCAVCLKIF-SFHVURJKSA-N	526475	US11186566, Compound 14	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				 40.0					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526475	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526475&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134393502	463790113							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113504	COc1ccccc1S(=O)(=O)NC(=O)c1ccc(nc1N1C[C@@H](C)CC1(C)C)-n1ccc(OCC2(CC2)C(F)(F)F)n1	InChI=1S/C28H32F3N5O5S/c1-18-15-26(2,3)35(16-18)24-19(25(37)34-42(38,39)21-8-6-5-7-20(21)40-4)9-10-22(32-24)36-14-11-23(33-36)41-17-27(12-13-27)28(29,30)31/h5-11,14,18H,12-13,15-17H2,1-4H3,(H,34,37)/t18-/m0/s1	GHASNKRJUHCHNZ-SFHVURJKSA-N	526514	US11186566, Compound 53	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				 40.0					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526514	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526514&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134393694	463790149							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113505	C[C@@H]1CN(c2nc(ccc2C(=O)NS(=O)(=O)c2ccccc2)-n2ccc(OCC3(CCC3)C(F)(F)F)n2)C(C)(C)C1	InChI=1S/C28H32F3N5O4S/c1-19-16-26(2,3)35(17-19)24-21(25(37)34-41(38,39)20-8-5-4-6-9-20)10-11-22(32-24)36-15-12-23(33-36)40-18-27(13-7-14-27)28(29,30)31/h4-6,8-12,15,19H,7,13-14,16-18H2,1-3H3,(H,34,37)/t19-/m0/s1	VOBJZDVBQBIDGT-IBGZPJMESA-N	526471	US11186566, Compound 10	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				 40.0					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526471	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526471&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134393695	463790109							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113506	C[C@@H]1CN(c2nc(ccc2C(=O)NS(=O)(=O)c2ccccc2)-n2nc(OCCC3(CC3)C(F)(F)F)cc2F)C(C)(C)C1	InChI=1S/C28H31F4N5O4S/c1-18-16-26(2,3)36(17-18)24-20(25(38)35-42(39,40)19-7-5-4-6-8-19)9-10-22(33-24)37-21(29)15-23(34-37)41-14-13-27(11-12-27)28(30,31)32/h4-10,15,18H,11-14,16-17H2,1-3H3,(H,35,38)/t18-/m0/s1	RYEXNMQWIOOZOE-SFHVURJKSA-N	526493	US11186566, Compound 32	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				 40.0					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526493	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526493&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134393696	463790130							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113507	C[C@@H]1CN(c2nc(ccc2C(=O)NS(=O)(=O)c2cccc(F)c2)-n2ccc(OCC3(CC3)C(F)(F)F)n2)C(C)(C)C1	InChI=1S/C27H29F4N5O4S/c1-17-14-25(2,3)35(15-17)23-20(24(37)34-41(38,39)19-6-4-5-18(28)13-19)7-8-21(32-23)36-12-9-22(33-36)40-16-26(10-11-26)27(29,30)31/h4-9,12-13,17H,10-11,14-16H2,1-3H3,(H,34,37)/t17-/m0/s1	VBYWIASXKMBLHM-KRWDZBQOSA-N	526512	US11186566, Compound 51	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				 50.0					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526512	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526512&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134393697	463790147							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113508	C[C@@H]1CN(c2nc(ccc2C(=O)NS(=O)(=O)c2ccccc2)-n2ccc(OCC3(CC3)C(F)F)n2)C(C)(C)C1	InChI=1S/C27H31F2N5O4S/c1-18-15-26(2,3)33(16-18)23-20(24(35)32-39(36,37)19-7-5-4-6-8-19)9-10-21(30-23)34-14-11-22(31-34)38-17-27(12-13-27)25(28)29/h4-11,14,18,25H,12-13,15-17H2,1-3H3,(H,32,35)/t18-/m0/s1	JSWYUNXPDUYODY-SFHVURJKSA-N	526516	US11186566, Compound 55	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				 50.0					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526516	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526516&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134393655	463790151							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113509	C[C@@H]1CN(c2nc(ccc2C(=O)NS(=O)(=O)c2cccc(F)c2)-n2ccc(OCCC3(CC3)C(F)(F)F)n2)C(C)(C)C1	InChI=1S/C28H31F4N5O4S/c1-18-16-26(2,3)36(17-18)24-21(25(38)35-42(39,40)20-6-4-5-19(29)15-20)7-8-22(33-24)37-13-9-23(34-37)41-14-12-27(10-11-27)28(30,31)32/h4-9,13,15,18H,10-12,14,16-17H2,1-3H3,(H,35,38)/t18-/m0/s1	DFLNZIUOSDIYMD-SFHVURJKSA-N	526468	US11186566, Compound 5	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				 50.0					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526468	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526468&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134393478	463790106							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113510	C[C@@H]1CN(c2nc(ccc2C(=O)NS(=O)(=O)c2ccccc2C)-n2ccc(OCC3(CCC3)C(F)(F)F)n2)C(C)(C)C1	InChI=1S/C29H34F3N5O4S/c1-19-16-27(3,4)36(17-19)25-21(26(38)35-42(39,40)22-9-6-5-8-20(22)2)10-11-23(33-25)37-15-12-24(34-37)41-18-28(13-7-14-28)29(30,31)32/h5-6,8-12,15,19H,7,13-14,16-18H2,1-4H3,(H,35,38)/t19-/m0/s1	XQRPBALBOHJZSL-IBGZPJMESA-N	526519	US11186566, Compound 58	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				 50.0					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526519	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526519&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134393698	463790154							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113511	C[C@@H]1CN(c2nc(ccc2C(=O)NS(=O)(=O)c2ccccc2)-n2ccc(OCC3C4(CC4)C33CC3)n2)C(C)(C)C1	InChI=1S/C30H35N5O4S/c1-20-17-28(2,3)34(18-20)26-22(27(36)33-40(37,38)21-7-5-4-6-8-21)9-10-24(31-26)35-16-11-25(32-35)39-19-23-29(12-13-29)30(23)14-15-30/h4-11,16,20,23H,12-15,17-19H2,1-3H3,(H,33,36)/t20-/m0/s1	IDAVUDFCPPOLFJ-FQEVSTJZSA-N	526523	US11186566, Compound 63::US11186566, Compound 64	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				 50.0					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526523	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526523&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134393681	463790158							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113512	C[C@@H]1CN(c2nc(ccc2C(=O)NS(=O)(=O)c2ccccc2Cl)-n2ccc(OCCC3(CC3)C(F)(F)F)n2)C(C)(C)C1	InChI=1S/C28H31ClF3N5O4S/c1-18-16-26(2,3)36(17-18)24-19(25(38)35-42(39,40)21-7-5-4-6-20(21)29)8-9-22(33-24)37-14-10-23(34-37)41-15-13-27(11-12-27)28(30,31)32/h4-10,14,18H,11-13,15-17H2,1-3H3,(H,35,38)/t18-/m0/s1	HWRRKFSXPSUGLD-SFHVURJKSA-N	526504	US11186566, Compound 43	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				 50.0					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526504	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526504&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134393618	463790140							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113513	C[C@@H]1CN(c2nc(ccc2C(=O)NS(=O)(=O)c2ccccc2)-n2ccc(OCCC(C3CC3)C3CC3)n2)C(C)(C)C1	InChI=1S/C31H39N5O4S/c1-21-19-31(2,3)35(20-21)29-26(30(37)34-41(38,39)24-7-5-4-6-8-24)13-14-27(32-29)36-17-15-28(33-36)40-18-16-25(22-9-10-22)23-11-12-23/h4-8,13-15,17,21-23,25H,9-12,16,18-20H2,1-3H3,(H,34,37)/t21-/m0/s1	RLNQVOHHZYRBIX-NRFANRHFSA-N	526503	US11186566, Compound 42	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				 50.0					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526503	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526503&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134393616	463790139							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113514	C[C@@H]1CN(c2nc(ccc2C(=O)NS(=O)(=O)c2ccccc2)-n2ccc(OCC(C3CC3)C3CC3)n2)C(C)(C)C1	InChI=1S/C30H37N5O4S/c1-20-17-30(2,3)34(18-20)28-24(29(36)33-40(37,38)23-7-5-4-6-8-23)13-14-26(31-28)35-16-15-27(32-35)39-19-25(21-9-10-21)22-11-12-22/h4-8,13-16,20-22,25H,9-12,17-19H2,1-3H3,(H,33,36)/t20-/m0/s1	WVFYUIWSILSHHL-FQEVSTJZSA-N	526502	US11186566, Compound 41	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				 70.0					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526502	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526502&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134393608	463790138							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113515	C[C@@H]1CN(c2nc(ccc2C(=O)NS(=O)(=O)c2ccc(C)cc2)-n2ccc(OCC3(CC3)C(F)(F)F)n2)C(C)(C)C1	InChI=1S/C28H32F3N5O4S/c1-18-5-7-20(8-6-18)41(38,39)34-25(37)21-9-10-22(32-24(21)35-16-19(2)15-26(35,3)4)36-14-11-23(33-36)40-17-27(12-13-27)28(29,30)31/h5-11,14,19H,12-13,15-17H2,1-4H3,(H,34,37)/t19-/m0/s1	GJEHRZGUQNDWJG-IBGZPJMESA-N	526485	US11186566, Compound 24	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				 70.0					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526485	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526485&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134393699	463790122							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113516	C[C@@H]1CN(c2nc(ccc2C(=O)NS(=O)(=O)c2ccccc2)-n2ccc(COCC3(CC3)C(F)(F)F)n2)C(C)(C)C1	InChI=1S/C28H32F3N5O4S/c1-19-15-26(2,3)35(16-19)24-22(25(37)34-41(38,39)21-7-5-4-6-8-21)9-10-23(32-24)36-14-11-20(33-36)17-40-18-27(12-13-27)28(29,30)31/h4-11,14,19H,12-13,15-18H2,1-3H3,(H,34,37)/t19-/m0/s1	GYQTXCNCGVCKPK-IBGZPJMESA-N	526498	US11186566, Compound 37	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				 70.0					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526498	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526498&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134393584	463790134							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113517	C[C@@H]1CN(c2nc(ccc2C(=O)NS(=O)(=O)c2ccccc2)-n2ccc(O[C@H]3C[C@H]4CC[C@@H]3C4)n2)C(C)(C)C1	InChI=1S/C29H35N5O4S/c1-19-17-29(2,3)33(18-19)27-23(28(35)32-39(36,37)22-7-5-4-6-8-22)11-12-25(30-27)34-14-13-26(31-34)38-24-16-20-9-10-21(24)15-20/h4-8,11-14,19-21,24H,9-10,15-18H2,1-3H3,(H,32,35)/t19-,20-,21+,24-/m0/s1	GQAUQTVFUGMNKL-JCUDRXCFSA-N	526500	US11186566, Compound 39	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				 70.0					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526500	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526500&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134393597	463790136							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113518	C[C@@H]1CN(c2nc(ccc2C(=O)NS(=O)(=O)c2ccccc2)-n2ccc(OCC3C(C)(C)C3(C)C)n2)C(C)(C)C1	InChI=1S/C30H39N5O4S/c1-20-17-28(2,3)34(18-20)26-22(27(36)33-40(37,38)21-11-9-8-10-12-21)13-14-24(31-26)35-16-15-25(32-35)39-19-23-29(4,5)30(23,6)7/h8-16,20,23H,17-19H2,1-7H3,(H,33,36)/t20-/m0/s1	GOJWWVIQSAHVSB-FQEVSTJZSA-N	526491	US11186566, Compound 30::US11186566, Compound 36	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				 90.0					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526491	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526491&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134393569	463790128							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113519	COc1ccc(c(C)c1)S(=O)(=O)NC(=O)c1ccc(nc1N1C[C@@H](C)CC1(C)C)-n1ccc(OCC2(CC2)C(F)(F)F)n1	InChI=1S/C29H34F3N5O5S/c1-18-15-27(3,4)36(16-18)25-21(26(38)35-43(39,40)22-8-6-20(41-5)14-19(22)2)7-9-23(33-25)37-13-10-24(34-37)42-17-28(11-12-28)29(30,31)32/h6-10,13-14,18H,11-12,15-17H2,1-5H3,(H,35,38)/t18-/m0/s1	PJXGOUOTBLFYPP-SFHVURJKSA-N	526518	US11186566, Compound 57	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				 80.0					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526518	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526518&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134393700	463790153							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113520	COc1ccc(c(OC)c1)S(=O)(=O)NC(=O)c1ccc(nc1N1C[C@@H](C)CC1(C)C)-n1ccc(OCC2(CC2)C(F)(F)F)n1	InChI=1S/C29H34F3N5O6S/c1-18-15-27(2,3)36(16-18)25-20(26(38)35-44(39,40)22-8-6-19(41-4)14-21(22)42-5)7-9-23(33-25)37-13-10-24(34-37)43-17-28(11-12-28)29(30,31)32/h6-10,13-14,18H,11-12,15-17H2,1-5H3,(H,35,38)/t18-/m0/s1	FRLLUAZJYAWRMP-SFHVURJKSA-N	526474	US11186566, Compound 13	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				 110					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526474	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526474&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134393701	463790112							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113521	C[C@@H]1CN(c2nc(ccc2C(=O)NS(=O)(=O)c2ccc(O)cc2)-n2ccc(OCC3C(C)(C)C3(C)C)n2)C(C)(C)C1	InChI=1S/C30H39N5O5S/c1-19-16-28(2,3)34(17-19)26-22(27(37)33-41(38,39)21-10-8-20(36)9-11-21)12-13-24(31-26)35-15-14-25(32-35)40-18-23-29(4,5)30(23,6)7/h8-15,19,23,36H,16-18H2,1-7H3,(H,33,37)/t19-/m0/s1	OSQOAKLGZVVFDM-IBGZPJMESA-N	526494	US11186566, Compound 33	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				 80.0					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526494	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526494&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134393574	463790131							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113522	C[C@@H]1CN(c2nc(ccc2C(=O)NS(=O)(=O)c2ccccc2)-n2ccc(OCC3C[C@@H]4CC[C@@H]3C4)n2)C(C)(C)C1	InChI=1S/C30H37N5O4S/c1-20-17-30(2,3)34(18-20)28-25(29(36)33-40(37,38)24-7-5-4-6-8-24)11-12-26(31-28)35-14-13-27(32-35)39-19-23-16-21-9-10-22(23)15-21/h4-8,11-14,20-23H,9-10,15-19H2,1-3H3,(H,33,36)/t20-,21+,22+,23?/m0/s1	DTQWKWKBVCMSDS-PZKXETHGSA-N	526501	US11186566, Compound 40	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				 80.0					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526501	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526501&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134393702	463790137							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113523	C[C@@H]1CN(c2nc(ccc2C(=O)NS(=O)(=O)c2ccc(cc2)C#N)-n2ccc(OCC3(CC3)C(F)(F)F)n2)C(C)(C)C1	InChI=1S/C28H29F3N6O4S/c1-18-14-26(2,3)36(16-18)24-21(25(38)35-42(39,40)20-6-4-19(15-32)5-7-20)8-9-22(33-24)37-13-10-23(34-37)41-17-27(11-12-27)28(29,30)31/h4-10,13,18H,11-12,14,16-17H2,1-3H3,(H,35,38)/t18-/m0/s1	DNBVDDUXBCUVLE-SFHVURJKSA-N	526488	US11186566, Compound 27	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				 270					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526488	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526488&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134393703	463790125							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113524	C[C@@H]1CN(c2cc(ncc2C(=O)NS(=O)(=O)c2ccccc2)-n2ccc(OCCC3(CC3)C(F)(F)F)n2)C(C)(C)C1	InChI=1S/C28H32F3N5O4S/c1-19-16-26(2,3)35(18-19)22-15-23(32-17-21(22)25(37)34-41(38,39)20-7-5-4-6-8-20)36-13-9-24(33-36)40-14-12-27(10-11-27)28(29,30)31/h4-9,13,15,17,19H,10-12,14,16,18H2,1-3H3,(H,34,37)/t19-/m0/s1	CSWLBFSSPPIMRB-IBGZPJMESA-N	526505	US11186566, Compound 44	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				 620					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526505	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526505&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134393622	463790141							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1113525	C[C@@H]1CN(c2nc(ccc2C(=O)NS(=O)(=O)c2ccc(O)cc2)-n2ccc(OCC3(CC3)C(F)(F)F)n2)C(C)(C)C1	InChI=1S/C27H30F3N5O5S/c1-17-14-25(2,3)34(15-17)23-20(24(37)33-41(38,39)19-6-4-18(36)5-7-19)8-9-21(31-23)35-13-10-22(32-35)40-16-26(11-12-26)27(28,29)30/h4-10,13,17,36H,11-12,14-16H2,1-3H3,(H,33,37)/t17-/m0/s1	VMVXOUKCKHODNH-KRWDZBQOSA-N	526483	US11186566, Compound 22	Cystic fibrosis transmembrane conductance regulator [1-507,509-1480]	Human				 120					US Patent		10.7270/Q22R3VVH		aid1806126	US11186566	Alcacio, T; Baek, M; Grootenhuis, P; Hadida Ruah, SS; Hughes, RM; Keshavarz-Shokri, A; McAuley-Aoki, R; McCartney, J; Miller, MT; Van Goor, F; Zhang, B; Anderson, C; Cleveland, T; Frieman, BA; Khatuya, H; Joshi, PV; Krenitsky, PJ; Melillo, V; Pierre, FJ; Termin, AP; Uy, J; Zhou, J; Abela, AR; Busch, BB; Paraselli, P	11/30/2021	4/9/2022	Vertex Pharmaceuticals Incorporated	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=526483	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=340&target=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=526483&enzyme=Cystic+fibrosis+transmembrane+conductance+regulator+%5B1-507%2C509-1480%5D&column=ki&startPg=0&Increment=50&submit=Search			134393704	463790120							1	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL	2PZE,2PZF,5TF7,5TF8,5TFA,5TFB,5TFC,5TFD,5TFF,5TFG,5TFI,5TFJ,5TGK,6GJS,6GK4,6GKD,6WBS	Cystic fibrosis transmembrane conductance regulator	CFTR_HUMAN	P13569	Q20BG8 Q20BH2 Q2I0A1 Q2I102